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The genus Aspergillus was first described by Micheli in the year 1725. He named the fungus 
Aspergillus because of the resemblence of the conidiophore and conidia to the Aspergillum, which 
was used to sprinkle holy water (aspergere). This figure shows an Aspergillum dated between 1709 
and 1746 (reprinted with permission of the Rijksmuseum Catherijneconvent, Utrecht, The 
Netherlands). 
GENERAL INTRODUCTION 
(Adapted and translated from: Verweij PE, de Pauw BE, Hoogkamp-Korstanje JAA, 
Kullberg BJ, Meis JFGM. Invasieve aspergillose: epidemiologie, diagnose en therapie. 
Ned Tijdschr Geneeskd 1994;138:752-7). 
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General introduction 
Aspergillus is a saprophytic fungus which is ubiquitous throughout the world. Although 
more than one hundred Aspergillus species are known, only 16 have been documented as 
etìologic agent in human disease68. Aspergillus species can cause several clinical patholo-
gical conditions in humans, but the scope of this thesis includes only the invasive 
pulmonary infections. The use of immunosuppressive treatment over the past 30 years has 
led to an increase in the incidence of opportunistic infections with Aspergillus species, and 
it is now the second most common systemic mycosis in immunocompromised patients14. 
Patients at high risk of invasive aspergillosis include patients with AIDS, those who are 
granulocytopenic as a result of cytotoxic therapy, patients receiving prolonged courses of 
high-dose corticosteroids and recipients of organ transplants. 
The sources of Aspergillus conidia include contaminated ventilatory and airconditioning 
systems, potted plants and, in particular, construction work carried out in or near 
hospitals8. Invasive aspergillosis is considered a nosocomial infection, the route of entry 
usually being the inhalation of airborne Aspergillus conidia which may primarily cause a 
pulmonary infection. In immunocompromised patients germination of Aspergillus conidia 
and tissue invasion cannot be prevented due to the elimination of normal defense 
mechanisms'32. The etiological agents of invasive aspergillosis include Aspergillus fianiga-
tus and A. flavus. Although, approximately 90% of invasive Aspergillus infections 
concern invasive pulmonary disease, dissemination to other organs such as the brain, liver 
and kidneys may occur. 
Incidence data of invasive aspergillosis in high risk patient groups are based on autopsy 
findings because of the difficulty in establishing an antemortem diagnosis. Although the 
overall incidence of invasive aspergillosis, even in those predisposed, is variable and 
often unpredictable, an increase of the number of invasive Aspergillus infections has been 
reported14. More intensive and effective cytotoxic treatment regimens resulting in 
enhanced mucosal damage and prolonged neutropenia and thrombocytopenia may acount 
for the rise of the incidence. At the University Hospital Nijmegen fungal infections were 
the established cause of death at autopsy in 36% of patients with hematological malignan-
cies during the period 1987-1992, of which 41% was caused by Aspergillus species. 
The prognosis of patients with suspected invasive aspergillosis is very poor and depends 
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on a number variables, such as remission of underlying disease, the certainty of the 
diagnosis, the early administration of antifungal treatment' and recovery of the granulocy­
tes (Table 1). 
Table 1. Mortality of invasive aspergillosis in treated and untreated patients and the certainty of 
Я е д і і а Л
, м и л , 4 Ы в
. 
Aspergillus Infection Mortality (%) 
Untreated Treated 
Proven* 90 60-90 
Probable" 70 30-40 
Possible0 30 5 
'Histopathological evidence for tissue invasion in tissue sections and/or positive biopsy culture. 
'Persistent fever despite the administration of broadspectrum antimicrobial agents, pulmonary 
infiltrates on the chest X-ray and, Aspergillus species cultured from sputum or BAL fluid samples. 
'Persistent fever despite broadspectrum antibiotics and pulmonary infiltrates on the chest X-ray, 
but culture for Aspergillus species negative. 
The main difficulty in the management of invasive aspergillosis remains the diagnosis of 
the infection at an early stage of disease. The clinical presentation of invasive aspergil­
losis is often non-specific and typical pulmonary signs such as cough and dyspnoea may 
be absent in the early stages of infection. Fever is frequently found, but may be masked 
by the use of corticosteroids. Plain chest X-ray films lack specificity and sensitivity in 
neutropenic patients, and typical infiltrates, such as the air-crescent sign, often develop 
during advanced disease or after recovery of the granulocytes61. A definitive etiological 
diagnosis of invasive aspergillosis can be established only by the demonstration of 
mycelial elements in tissue and by recovering Aspergillus species in culture. However, the 
presence of severe thrombocytopenia often precludes the use of invasive diagnostic 
methods to obtain affected tissue samples, and therefore fiber-optic bronchoscopy is 
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commonly used to obtain a specimen for diagnosis31. The conventional microbiological 
techniques which are used to diagnose invasive aspergillosis include culture of sputum or 
bronchoalveolar lavage (BAL) fluid samples. Aspergillus species may be isolated from 
these specimens by culture on Sabouraud medium, incubated at 42°C. However, the 
sensitivity of culture from sputum samples and BAL fluid samples is low, 23 %tl and 40-
58%5J,e1,10*'146 respectively. Although a positive culture result is highly indicative of 
Aspergillus infection in neutropenic patients14*, the interpretation of a positive Aspergillus 
culture result remains difficult because conidia may contaminate the specimen. 
The detection of specific znû-Aspergillus antibodies in serum has demonstrated poor 
sensitivity in immunocompromised patients14' and therefore tests have been developed 
which detect Aspergillus antigens, especially the polysaccharide galactomannan114. Several 
serological tests have been developed which allowed detection of Aspergillus antigens in 
serum, urine and BAL fluid, but the sensitivity of these tests is too low to early diagnose 
invasive aspergillosis. 
The aim of this thesis is to develop and evaluate techniques which may allow the 
microbiological diagnosis of invasive aspergillosis at an early stage of infection. 
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DNA-BASED DETECTION OF ASPERGILLUS 

Chapter 1.1 
PYLOGENETIC RELATIONSHIPS OF FTVE SPECIES OF ASPERGILLUS AND 
RELATED TAXA AS DEDUCED BY COMPARISON OF SEQUENCES OF SMALL 
SUBUNIT RIBOSOMAL RNA 
P.E. Verweij, J.F.G.M. Meis, P. Van Den Hurk, J. Zoll, R.A. Samson, 
and W.J.G. Melchers 
Journal of Medical and Veterinary Mycology 1995;33:185-90. 
Reprinted with permission, Blackwell Science, Oxford, U.K. 
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Summary 
The nucleotide sequences of the genes encoding the 18S rRNA of Aspergillus flavus, A. 
nidulans, A. terreus and A. niger were elucidated and aligned to the sequences of A. 
fitmigatus. In addition, the 18S rRNA sequences of the V4 - V9 region of morphological-
ly similar filamentous fungi, e.g. Pénicillium chrysogenum, P. mameffei and Paecilomy-
ces variotii, were elucidated. Phylogenetic analysis and comparison showed a very close 
intergeneric relationship of the genus Aspergillus to species of the genera Paecilomyces 
and Pénicillium. However, the sequenced Aspergillus species also showed a very close 
relationship to Eurotium rubrum and Monascus purpureas. Phylogenetic analysis of fungal 
18S rRNA sequences divided the genera Aspergillus, Pénicillium, and Paecilomyces into 
two coherent clusters and showed a close intergeneric relationship which is in keeping 
with the existing morphological and taxonomie classification. 
Introduction 
The genus Aspergillus is ubiquitous within the environment and is found throughout the 
world. Although clinical entities caused by Aspergillus species show great variety, the 
upper and lower respiratory tract are the main focus of primary infection. In immuno-
competent hosts, allergic reactions to inhaled Aspergillus conidia and saprophytic 
colonization of pre-existing cavities in the lung are the syndromes most frequently 
encountered68. Invasive pulmonary aspergillosis occurs in immunosuppressed patients and 
is the second most frequent cause of opportunistic fungal infection14. The pathogenesis 
involves inhalation of conidia followed by localized or disseminated disease. More than 
90% of the patients have either received corticosteroid therapy43, had prolonged neutrope-
nia41 or are receiving cytotoxic chemotherapy144. Although more than 180 Aspergillus 
species, with about 70 named teleomorphs have been listed95·106·107, only 16 species have 
been documented as etiologic agents of human disease68. A. fumigatus is the most 
common cause of both invasive and non-invasive aspergillosis worldwide14. To examine 
the origin of pathogenicity, it is important to determine the evolutionary relationships of 
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the Aspergillus species to each other, as well as similar fungi. 
The most important pathogenic species of Aspergillus, including A. fumigatus, A. flavus, 
A. terreus, and A. niger, are classified in an artificial system (Fungi Imperfecti), because 
they are not known to produce an ascomycetous state107, although A. fumigatus is 
associated with species of the ascomycete Neosartorya, and A. nidulans is known to 
produce a teleomorph in the genus Emericella. Although the conidial structures of 
aspergini are fairly uniform, the morphological features of the teleomorph, when present, 
are very diverse. The diversity of the cleistothecia and the absence of ascocarps in many 
species makes studies of evolution and phylogenetic relationships difficult. Therefore, 
molecular data obtained from ribosomal nucleotide sequences are increasingly used to 
elucidate fungal phytogeny38. These molecules are well suited as taxonomie tools because 
they are universally present and their function in protein synthesis is highly conserved 
both in pro- and eukaryotes8*. 
In addition, knowledge about the sequence variability exhibited by these fungi is of 
importance, because DNA amplification techniques using Aspergillus specific primers and 
oligonucleotide probes are increasingly implemented for the diagnosis of invasive 
aspergillosis78"1·119 and epidemiological analysis122. 
Here we describe the phylogenetic relationships of five pathogenic Aspergillus species 
based on 18S rRNA sequence analysis and attempt to relate these results to the presently 
known taxonomie situation. Two species of Pénicillium, P. mameffei and P. chrysoge-
num and the morphologically related species Paecilomyces variotii were also included in 
the comparison because high levels of homology with Aspergillus have been reported78,111. 
Materials and Methods 
Organisms 
A. flavus (CBS 108.30; source: ex Pseudococcus), A. nidulans (CBS 100.20; source: ex 
man), A. terreus (CBS106.25; source: unknown), A. niger (CBS102.12; source: un-
known, type of A. niger mutant altipes), and P. mameffei (CBS 385.89; source: ex man) 
were obtained from the Centraalbureau voor Schimmelcultures (CBS, Baarn, The 
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Netherlands). P. chrysogenum (AZN 1126; source: ex man) and Paecilomyces variotii 
(AZN 731; source: ex man) were isolated at our hospital. All fungi were grown in culture 
on Sabouraud agar at 28°C for 4 days. Mycelial growth was peeled off from the agar 
surface using sterile forceps, and suspended in 600 μί distilled water. This suspension was 
added to 1 ml of 0. S mm zirconium beads which had been washed and autoclaved in 
0.2% sodium dodecyl sulphate in 1 M sodium bicarbonate. Complete cell destruction was 
achieved by high frequency shaking at 6000 rev. min' for 160 sec in a MiniBeadbeater 
system (Tecnolab., Alkmaar, The Netherlands). Next, the mixture was centrifuged for 15 
min at 1500 g. DNA was purified successively by phenol, phenol-chloroform-isoamyl 
alcohol (25:24:1) and chloroform-isoamyl alcohol extraction74 followed by precipitation 
with ethanol overnight at -20° С. DNA was finally dissolved in 100 μί distilled water. 
PCR amplification 
The complete 18S rDNA was amplified by PCR using general eukaryotic 5' and 3' 18S 
rDNA primers 5'-CCTGGTTGATCCTGCCAGTA-3' and 5'- GCTTGATCCTTCTGCA-
GGTT-3' respectively27. PCR was performed in a 100 μί reaction mixture containing 10 
mM Tris-HCL (pH 9.0 at 25°C), 10 mM KCl, 1.4 mM MgCl2, 0.2 mM of each dNTPs, 
0.1% Triton X-100, 50 pmol each of two primers, 0.2 U superTaq DNA polymerase (HT 
Biotechnology, Cambridge, UK) and 0.5 /tg DNA of each Aspergillus, Pénicillium or 
Paecilomyces isolate which had been denatured at 94°C for 5 min. Next, 30 cycles of 
amplification were performed by denaturating for 1 min at 94°C, annealing the primer for 
1 min at 42°C and allowing elongation for 3 min at 72°C. When successful, amplification 
generated a product of approximately 1800 basepairs. Each product was analyzed by 
electrophoresis in 1.5% agarose gels. The amplification products required for sequencing 
were purified from low-melting agarose (LKB) using the Prep-a-Gene system (BioRad 
Laboratories, Veenendaal, the Netherlands). DNA sequencing was performed by the 
dideoxy nucleotide method"* using the Taq DyeDeoxy Terminator Cycle Sequencing Kit 
(Applied Biosystems, Gouda, the Netherlands) according to the manufacturer's instructi-
ons. The nucleotide sequence was determined in both directions. Sequencing reactions 
were analysed on an Applied Biosystems 373A DNA sequencer. Primers selected from 
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several conserved regions of the 18S RNA served as sequencing primers (Table 1). From 
A. flavus, A. nidulans, A. terreus and A. niger the complete nucleotide sequence of the 
18S rRNA was determined, and from P. chrysogenum, P. mameffei, and Paecilomyces 
variotii the nucleotide sequence of the V4 - V9 region. 
Table 1. List of primers used to determine the sequence ofl8S rDNA of A. flavus, A. terreus, A. 
nidulans, A. niger, Pénicillium mameffei, P. chrysogenum, and Paecilomyces variotii. 
Primer 
P56.1 
P35.1 
P36.1 
P55.4 
P55.7 
P55.ll 
P81.1 
P55.13 
P55.15 
P55.17 
P35.2 
P35.3 
P36.2 
P55.5 
P55.6 
P55.8 
P55.9 
P55.10 
P81.2 
P56.2 
Orientation 
5'-3' 
5'-3' 
5'-3' 
5'-3' 
5--3' 
5'-3" 
5'-3' 
5'-3' 
5*-3· 
5'-3· 
3'-5· 
3'-5* 
3'-5* 
3--5* 
3'-5' 
3'-5' 
3'-5' 
3'-5' 
3'-5' 
3'-5' 
Sequence (5'-3') 
CCTGGTTGATCCTGCCAGTA 
GAAACTGCGAATGGCTCATT 
ATTCCGGAGAAGGAGCCTGA 
GGTGCCAGCAGCCGCGGTAA 
GAGTGTTCAAAGCAGGCCTT 
AGGTGAAA1TC1TAGATTTG 
AAG ITITI GGGTTCTGGGGG 
GATTTGTCTGCTTAATTGCG 
CGCGCGCTACACTGACAGGG 
TACTACCGATTGAATGGCTC 
GG T1T1T1ATCTAATAAATA 
AATCGAACCCTAATTCTCCG 
GCAACAACTTTAATATACGC 
AAGGCCTGCTTTGAACACTC 
TTTCGCAGTAGTTAGTCTTC 
CAAAAACTTTGATTTCTCGT 
AGACAAATCACTCCACCAAC 
GGCATCACAGACCTGTTATT 
TACAAAGGGCAGGGACGTAA 
GCTTGATCCTTCTGCAGGTT 
Position 
2-22 
83-102 
376-395 
539-578 
761-780 
899-918 
1092-1112 
1301-1320 
1461-1480 
1640-1659 
201-220 
359-378 
593-612 
761-780 
921-940 
1081-1100 
1290-1309 
1421-1440 
1615-1634 
1784-1803 
Phylogenetic analysis 
The 18S rRNA sequences were aligned with other eukaryotic sequences available on the 
EMBL database. A subset of this alignment, including the presently sequenced fungi and 
23 other fungal 18S rRNA sequences (EMBL database), was selected for inference of 
phylogenetic trees. Sequence analysis and comparisons were made using PHYLIP version 
3.4 (the default of the program)35. Neighbour-joining105 and Fitch-Margoliash distance 
trees were inferred using NEIGHBOR and FITCH, respectively. The confidence limits in 
the trees were estimated by using the bootstrap method (SEQBOOT, 100 replicates)3*. 
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Nucleotide sequence accession numbers 
The 18S rRNA sequences of the Aspergillus species reported here have appeared in the 
EMBL, GenBank, and DDBJ nucleotide sequence data bases under the accession numbers 
X78537 {A. flavus), X78538 (A. niger), X78539 (A. nidulans), X78540 (A. terreus). 
Results 
Figure 1 shows the sequence alignment data of the 18S rRNA from the different Aspergil-
lus species. The sequence oí A. fitmigatus, which was published earlier by Bams et al.", 
was used as a template. A very extensive homology was found between P. chrysogenum, 
P. mameffei, Paecilomyces variotii, A. fitmigatus, and the presently sequenced Aspergillus 
species: A. flavus, A. niger, A. terreus, and A. nidulans for the V4 - V9 region of the 
18S rRNA gene. A representative collection of levels of evolutionary distance estimates is 
presented in Table 2. The regions V4 - V9 of the 18S rRNA, consisting of approximately 
1200 basepairs, were used to draw up a phylogenetic tree. The Fitch-Margolish distance 
tree is shown in Figure 2. Use of neighbour-joining methods gave trees topologically 
identical to that shown in Figure 2 in all major respects. The statistical reliability of this 
tree was examined by using the bootstrap method36, which estimates the uncertanty in a 
measurement due to a finite sample size (Figure 2). The fungi sequenced in this study 
were divided into two clusters of organisms with a high intersequence similarity. 
Pénicillium mameffei and P. chrysogenum were found to be very closely related to 
Paecilomyces variotii. The four sequenced Aspergillus species were also highly related to 
each other and to A. fitmigatus. Comparison with the 18S rRNA sequences of 23 other 
eukaryotes revealed a very close relationship between Aspergillus species and two other 
ascomycetous species, e.g. Eurotium rubrum and Monascus purpureus. 
Discussion 
The introduction of molecular criteria in fungal phylogeny has contributed to understan-
ding the evolution and phylogenetic relations of fungi. Branching patterns derived from 
12 
18S rRNA sequence and phylogeny о/" Aspergillus 
ó ó o o ó ö ó ö ö ó o o ó ö ó o 
o d o o ò d ò ò o ò ò d ò d o 
Ο Ο Ο Ο Ο Ο 9 Ν Ο ~ * < - * 0 0 1 Γ ) · Ν Γ » > 
о о о о о о ó о' о ó о о ó ó 
o o m O i S m - t v o a o o o o f - V i r * · 
ö o' o' ó o o o o' Ö o o ó о 
ö o d o o ö ö d ö ö o ö 
S S S S S S S S S S 8 
o d d o d ò o ó ó o d 
f - v O ^ v o O ^ v O — Q — 
o o o o o o p o o o 
o d ¿ о о о o o o o' 
ooo\«cj\o\t>»nt**r~ 
o o o o o o o q b 
О О О О О О О О О 
m r Ñ ^ f N m c N c n — o q q o o o o o 
ó ö ö ó ö ó ö o 
· * — m (M in — oo 
S S S S S S S 
о о о d d d о 
ο ο Ό г- οο *η 
S q S ο S о 
ó ö ó ó Ь ò 
5 8 8 
о d d d о 
Ν - О «0 
- - N O 
о о о S 
d o o d 
о о\ 
q S 
o d d 
tN о 
δ S 
d d 
4. 
І 
2 
00 
e 
.2 
•i 
j 
Ui 
•а 
- М П * 
13 
Chapter IJ 
У I I 140 
A f i e l o a t u e AACCTGGTTG ATCCTGCCAG TAGTCATATG CTTCTCTCAA AGATTAAGCC ATGCAT6TCT AAfiTATAACC AATTTATACG GTCAAACTGC 6AATCGCTCA TTAAATCACT TATCGTTTAT TT6ATA6TAC CTΤACTАСАΤ 
Α Π 1β· г С Τ 
A t e r r e t e C T G 
A f i · « * С Τ 
A m il· Lm« с τ 
Ρ var tot i i 
Ρ сЬгу Явпмг 
Ρ a e r n e f f e l 
V2 
U I 280 
A fi«1o»tUS GGATACCTGT GCTAATTCTA GAfiCTAATAC ATGCTAAAAA CCTCCACTTC GGAAGGGGTG TATTTATTAG АТДАААААСС AATGCCCTTC GGGGCTCCTT G6T6AATCAT ААТААСТ1ДА CGAATCGCAT GGCCTTGCGC 
A n l 0 * r G N 
A t e r r e t e С Τ 
A flavUB Τ 
A n i d u l e m C G C T 
Ρ v e r l o t i ι 
Ρ chryvofrena-
Ρ H m e f f e i 
281 420 
A f i n ì » · t i e CGSCSATCCT TCATTCAAAT TTCTGCCCTA TCAACTTTCG ATGG1ACGAT AGTGSCCTAC CATGGTGGCA ACGGCTAACG GGGAATTAGG GTTCGATTCC QGACAGGCAG CCTGA6AAAC GOCTACCACA TCCAAGGAAG 
A moer 
A t e r r e t e 
A f l a v t a 
A ni dut an» 
Ρ v e n t i t i t 
Ρ chryMoanar-
Ρ n r r w f f e l 
з 
421 I 
A f u B i o a t i » 6CA6CACCC6 CGCAMTTAC CCAATCCCGA CACSfifiCAGC TAGTGACAAT AAATACTGAT ACGCGGCTCT TTTGGGTCTC GTAATTGGAA TGAGTACAAT CTAAATCCCT TAACGAGGAA І 
A n i g i r С 
A t e r r « u i 
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A nfdulan» A Τ 
Ρ v a r l o t H 
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Γ TGAACt 
A f i H l f l v t i S TGCCAGCAGC COCG6TAATT CCAGCTCCAA TAGCCTATAT TAAAGTTGTT GCAGTTAAAA АБСТСвТАбТ TGAACCTTGG GTCTGGCTGS CCGGTCCGCC TCACC6C6A6 TACTGGTCCG GCTGCACCTT TCCTTCTGGG 
A nloar 
A t e r г е ш 
A f lavua 
A nidutan» 
Ρ v a r i a t i 1 Η 
Ρ chrysogerui И 
Ρ BBrneffef С С Τ CT A G Τ Η 
V4 
701 840 
A f U i l g * t i e GAACCTCATG GCCTTCACTG GCTGTGG GG GGAACCAGGA CTTTTACTGT GAMAAATTA GAGTGTTCAA AGCAGGCCTT TGCTCGAATA CATTAGCATG GAATAATAGA ATAGGACGTG CGGTTCTATT TTGTTGGTTT 
A n l n t r TTC 
A t e r r e u a TTC 
A f l a w » Τ AG 
A η dui ans С G 
Ρ var i e t l i С С С Τ 
Ρ chr-psogenu· Τ 
Ρ w r n e f f e i Т С С N G 
841 «60 
A f m l o a t u a CTAGGACCGC CGTAATGATT AATAGGGATA GTCGGGCGCG TCAGTATTCA GCTGTCAGAG GTGAAATTCT TGCATTTGCT GAAGACTAAC TACTGCGAAA GCATTCGCCA AGGATGTTTT CATTAATCAG GGAACGAAAG 
A m g a r 
A terreus 
A І і в ш 
A ni dut m » 
Ρ v a r l o t i l N T H 
Ρ сЬгщоаспші Τ 
Ρ M r m f f e i M 
« 1 | | 1120 
A f tailsatu» TTAGGGGATC GAACACGATC AGATACCGTC GTAGTCTTAA CCATAAACTA TGCEGACTAG GGATCGGGCG GTGTTTCTAT GATGACCCGC TCGGCACCTT ACGAGAAATC AAAGTTTTTG GGTTCTGGGG GGAGTATGGT 
A ntger Τ Τ 
A tarraue 
A f i»vu» 
A ηi du lane G С Τ Τ 
Ρ v a r i o t i i A 1 Τ 
Ρ chryeogeftUB A A A Τ 
Ρ m r n a f f a i G 
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Figure L Sequence alignment of J8S rRNA of Aspergillus fumigatus, A. niger, A. terreus, A. 
flavus, A. nidulans, Paecilomyces variotii, Pénicillium chrysogenum, and P.marneffei, Nucleotide 
residues in the sequences of the isolates are indicated by V for corresponding residues; mutated 
residues are indicated by their corresponding letter, and N indicates uncertain residues; regions 
that were not sequenced are indicated by "-". The variable regions VI - V9 are indicated above 
the sequences. 
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18S rRNA12 and orotidine 5'-monophosphate decarboxylase protein sequence analysis94 
show that the ascomycetes initially split from the zygomycetes and basidiomyceres. The 
first branch in the ascomycete line seperates the budding yeasts from the filamentous 
ascomycetes. In the present study a phylogenetic trees was constructed for the 18S rRNA 
by neighbour-joining and Fitch-Margoliash analyses and was found to be similar to those 
reported by other investigators14. The sequenced species of the genera Aspergillus, 
Pénicillium and Paecilomyces were found to be closely related to each other and two 
coherent clusters were formed. High levels of intersequence similarities between morpho-
logical similar species of Aspergillus and Pénicillium was also demonstrated by Min-Wei 
Chen et al23. Our analysis, based on the fungal 18S rRNA sequence, confirms these 
findings and also suggests a close relationship of these taxa to Paecilomyces variotii. 
Paecilomyces variotii was found to be more closely related to Pénicillium than to 
Aspergillus. The conidiogenous structures of Paecilomyces variotii are similar to 
ΐ 
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Candida аіЫоап» 
ι сапою· пекл 
- | _ j - Candidi via«anai 
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Auraotoaaldiurn pullulane 
Hlatopleem« eepeuialui 
ι — Hiatopieem« eepeuiaium 
_ T ^ — Biaalgmycaa darmatitidie 
5Q I I Coccidioidal immiti· 
— J ι Trichophyton rubrum 
4 r ' Cramaaoua albu· 
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Sporsihrla »chançtill 
Figure 2. Fitch-Margoliash distance tree based upon analysis of the regions V4 - V9 of the 18S 
rRNA, consisting of approximately 1200 basepairs, showing intrageneric phylogenetic relations-
hips of five Aspergillus species and the position of these species with respect to Pénicillium, 
Paecilomyces and 22 other eukaryotes. Bootstrap values of major branches were displayed on the 
tree. Scale bar = 0.05 substitution per position. 
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Pénicillium species, differing by the shape of the philides and the branching pattern. It is 
therefore not surprising that this species clusters closely with the Pénicillium species 
examined. The latter belong to two different subgenera of Pénicillium, P. mameffei to 
subgenus Biverticillium and P. chrysogenum to subgenus Pénicillium. Accordingly, P. 
mameffei is more distantly related to P. chrysogenum. 
The intrageneric relationship of the Aspergillus species which were examined showed very 
high levels of intersequence similarities. Aspergillus fiimigatus and A. flavus were found 
to be closely related to each other and A. niger to A. terreus. The close relationship 
between A. fiimigatus and A. flavus is interesting because these are opportunistic patho-
gens most often encountered in invasive human disease. The highest divergence among 
the Aspergillus species in the present study was found between the cluster A. flavus and 
A. fiimigatus, and A. nidulans. These results differ from observations based on restriction 
endonuclease cleavage patterns of mitochondral DNA5'. In their study, the phylogenetic 
distance between A. nidulans and A. flavus was less than the distances between A. flavus 
and A. niger. However, SS rRNA sequence analysis of A. niger and A. flavus also 
showed very high levels of similarities55. Since these two species are also morphologically 
closely related they are placed in the subgenus Circumdati and no teleomorph are 
known106. 
Phylogenetic analysis showed that the two ascomycetous species E. rubrum and M. 
purpureus are also closely related to Aspergillus species. Although Eurotium has an 
Aspergillus anamorph, it is clearly different from the species examined. Monascus has a 
quite different Basipetospora anamorph and with respect to the morphology and taxonomy 
of these species, a close relation to Aspergillus is difficult to understand. Since the 
interpretation of the phylogenetic relationship of Eurotium and Monascus to Aspergillus is 
unclear, sequence data and phylogenetic analysis of more species within these genera are 
needed to gain more insight in the nature of this relationship. 
With exception of the fungi E. rubrum and M. purpureus, phylogenetic analysis of fungal 
18S rRNA sequences divided the genera Aspergillus, Pénicillium and Paecilomyces into 
two coherent clusters and showed a close intergeneric relationship which is in keeping 
with the existing morphological classification. 
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POLYMERASE CHAIN REACTION AS A DIAGNOSTIC TOOL FOR INVASIVE 
ASPERGILLOSIS: EVALUATION IN BRONCHOALVEOLAR LAVAGE FLUID 
FROM LOW RISK PATDÎNTS 
P.E. Verweij, J.F.G.M. Meis, P. van den Hurk, B.E. De Pauw, 
J.A.A. Hoogkamp-Korstanje, and W.J.G. Melchers 
Serodiagnosis and Immunotherapy in Infectious Disease 1994;6:203-8. 
Reprinted with permission, Elsevier Science Ltd, Kidlington, U.K. 
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Summary 
Ал Aspergillus genus-specific PCR, which has been developed for the diagnosis of 
invasive ¡""vaginosis (IA) in high risk patients78, was evaluated in 72 bronchoalveolar 
lavage (BAL) samples obtained from 70 non-neutropenic, low risk patients in order to 
establish the rate of detectable colonization with Aspergillus species of the respiratory 
tract. A ? ·Ήνε amplification was found in 11 out of 72 samples (15%). Risk factors for 
colonization, e.g. corticosteroid therapy and cigarette smoking, were present in 64% of 
the évaluable cases, and a significantly higher rate of colonization was found when risk 
factors were present (p < 0.05). The low rate of detectable colonization justifies further 
evaluation of this PCR assay in the diagnosis of IA. 
Introduction 
The genus Aspergillus is a saprophytic fungus which can cause severe pulmonary 
conditions in humans, including allergic bronchopulmonary aspergillosis, aspergilloma, 
and invasive aspergillosis (IA). Life threatening invasive infections by Aspergillus species 
increasingly occur in immunocompromised patients. Particulary at risk are leukemic pa-
tients with cytotoxic-induced neutropenia and transplant recipients receiving high-dose 
corticosteroid therapy. The diagnosis of IA in an early stage is of great importance, since 
early treatment with amphotericin В has been shown to reduce the mortality rate1. 
However, conventional diagnostic methods, e.g. culture of sputum81 or bronchoalveolar 
lavage (BAL) fluid51 and serology6, lack sensitivity and definite diagnosis is often made 
only at autopsy. In our hospital the diagnostic yield of cultures obtained from patients 
suspected for IA and proven at autopsy was 39%, but in half of these cases culture 
became positive only within 7 days before death126. Therefore, sensitive and reliable 
assays for the detection of IA in an early stage are needed. DNA-based methods for the 
detection of Aspergillus species have been developed and several studies have shown that 
PCR could detect Aspergillus DNA in BAL fluid samples of high risk patients with a very 
high sensitivity and specificity and the PCR may therefore be a promising diagnostic tool 
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for the diagnosis of IA 7 8 ·* 7 · 1 1 1 1 1 9 . However, since Aspergillus is also known to colonize the 
respiratory tract, the interpretation of a positive amplification can be difficult. The 
prevalence of detectable colonization of the respiratory tract with Aspergillus species is 
the most important issue that must be addressed in the clinical evaluation of the PCR. 
In the present study, we have evaluated a PCR assay by determining the rate of Aspergil­
lus species in BAL fluid obtained from non-neutropenic patients at low risk for IA and 
have compared this with the results obtained by culture. In addition, we have reviewed 
the patient records for risk factors for colonization of the respiratory tract with Aspergil­
lus species. 
Materials and Methods 
Clinical samples 
BAL fluid specimens (5-10 ml) from hospilatized patients, which were sent to the 
laboratory for microbiological analysis, were assigned a number and stored at -80 °C 
until use. BAL fluid samples from the Departments of Hematology and Oncology were 
excluded from the study. All samples were analysed without knowledge of the patients' 
medical history. After thawing, the BAL fluid samples were centrifuged at 2,500 rpm for 
15 min, and the supernatant was discarded leaving a residue of 0.5 ml in which the pellet 
was resuspended. One hundred μΐ of this suspension was added to 1 ml of 0.5-mm-
diameter zirconium beads which had been washed and autoclaved in 0.2% sodium 
dodecyl sulphate (SDS) in 1 M sodium bicarbonate. Complete cell destruction was 
achieved by high frequency shaking at 6000 vibrations per min for 160 sec in a Mini-
Beadbeater system (Tecnolab Int., Alkmaar, The Netherlands)7·. Next, the mixture was 
centrifuged for 15 sec at 11 000 rpm. Nucleic acids were purified by a guanidinium 
thiocyanate containing lysis buffer and silica particles, as descibed by Boom et al.17 and 
were finally dissolved in 100 μΐ of distilled water. The DNA content of each sample was 
determined by spectrophotometry (GeneQuant RNA/DNA Calculator, Pharmacia, 
Cambridge, UK). 
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Polymerase chain reaction 
All DNA samples were tested in two dilutions containing 0.1 μ% and 0.5 μ% of total 
DNA, for the presence of Aspergillus species by a hot-start PCR as described previous­
ly7*. Briefly, PCR was performed in a final reaction volume of 100 μΐ containing 75 mM 
Tris-HCl (pH 9.0 at 25 eC), 20 mM (NH^SO«, 0.01% Tween 20, 2.5 mM MgCl2, 0.33 
mM (each) deoxynucleoside triphosphates (dNTPs), 50 pmol of each of the two Aspergil­
lus genus-specific primers (Aspi, 5'-CGGCCCTrAAATAGCCCGGTC-3·; and Asp-2, 5'-
ACCCCCCTGAGCCAGTCCG-3'), 0.2 U of Taq DNA polymerase (Thermoperfect plus 
DNA polymerase, Integro, Zaandam, The Netherlands), and 0.1 μg or 0.5 μ% of DNA 
from each BAL fluid sample which had been pre-denatured at 94 °C for 5 min. Next, 40 
cycles of amplification were performed by denaturating for 1 min at 94°C, annealing the 
primer for 1 min at 62°C and allowing elongation for 1 min at 72"C. Internal control of 
DNA amplification of each sample was performed with the ß-globin primers PC03/ 
PC04, which amplify a 326-bp fragment of the ß-globin genel<n. 
Analysis of amplified DNA 
Aliquots of 25 μΐ samples were analysed by electrophoresis on a 1.5% agarose gel stained 
with ethidium bromide74. For Southern blotting, the agarose gel was depurinated in 0.25 
N HCl, denaturated in 0.5 N NaOH-1.5 M NaCl, and transferred to a nylon membrane 
(Hybond; Amersham Int., Bucks, England) by diffusion blotting in 0.5 N NaOH-1.5 M 
NaCl. DNA was covalently bound to the membrane by baking at 80 °C for 2 h. Hybrid­
ization was performed with an internal Aspergillus-specifw oligonucleotide probe (Asp-p, 
5'-ATGGAAGTGCGCGGCAATAAC-3'), which was non-radioactively labelled with 
Digoxigenin-11-dUTP (DIG oligonucleotide З'-end labeling kit, Boerhinger GmbH, 
Mannheim, Germany) according to the manufacturers instructions. The hybridization 
signal was detected on an X-ray film using a chemiluminescent substrate (Lumigentm 
PPD, Boehringer GmbH, Mannheim, Germany). All positive samples were confirmed to 
be Aspergillus specific by Styl restriction endonuclease digestion78. 
For prevention of contamination, the recommendations of Kwok and Higuchi67 were 
followed and each technical step was kept strictly isolated. Furthermore, a limited number 
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of five BAL fluid samples were analysed at a time. 
Culture results and patient records 
After the PCR analysis of the BAL fluid samples was completed, the results were 
compared with bacteriological, virological, parasitológica!, and mycological culture 
results. In addition, the patient records were reviewed for the following features: age, 
sex, leucocyte count, underlying disease, corticosteroid therapy, and cigarette smoking. 
Data analysis 
The Statistical Program for the Social Sciences (SPSS) was used for data-analysis. Chi-
square tests were used to determine statistical significance 
Results 
A total of 72 BAL fluid samples obtained from 70 patients, SO men and 20 women, were 
tested. The mean age of the patients was 52 years (range 4 - 8 8 ) . Patient records were 
available from 64 patients (91%), and the main underlying diseases are listed in Table 1. 
The patients were non-neutropenic and at low risk for IA, but 41 patients (64%) had risk 
factors for colonization of the respiratory tract with Aspergillus species (Table 1). The 
macroscopic aspect of the BAL fluid samples varied from clear to purulent and the mean 
concentration of DNA which was isolated from the BAL fluid specimens was 79 ng/μΐ 
(range 30 - 478 ng//il). Amplification with Aspergillus genus-specific primers and 
hybridization with an Aspergillus specific oligonucleotide probe was found positive in 11 
out of 72 (15%) of the BAL fluid samples (Table 1). Ten positive samples were obtained 
from patients with risk factors for colonization, and one sample was obtained from a 
patient without presence of the analyzed risk factors. However, the latter patient had a 
chronic granulomatous disease which is an additional risk factor for colonization and 
infection with Aspergillus. Statistical analysis showed that corticosteroid therapy and 
cigarette smoking were significantly associated with a positive PCR amplification (p < 
0.05). 
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Table 1. Underlying diseases and risk factors for colonization with Aspergillus species in 70 
patients at low risk for ¡A, and results of Aspergillus genus-specific PCR. 
Underlying disease 
Absent 
Transplantation 
kidney 
bone marrow 
Pulmonary conditions 
COPD 
malignancies 
TBC 
RA/SLE 
HIV / AroS 
Ulcerative colitis 
NIDDM 
Malignancies 
Other 
Unknown 
Number of 
patients 
4 
5 
1 
2 
4 
4 
5 
3 
2 
3 
10 
21 
6 
absent 
1 
1 
1 
1 
3 
6 
ц<|> 
Analysed 
cortico­
steroids 
3<i) 
1 
3 
2 
1 
2<2> 
risk factors 
smoking 
3d) 
1 
3 
2 
2<" 
3<i) 
6m 
both 
2 
1 
2 
1 
2® 
Total 70 
<1)/<2)
=number of patients with a positive Aspergillus genus-specific PCR amplification; COPD = 
chronic obstructive pulmonary disease; TBC = tuberculosis; RA = rheumatoid arthritis; SLE = 
systemic lupus erythemathodus; HIV = human immunodeficiency vims; AIDS = acquired 
immunodeficiency syndrome; NIDDM = non-insulin dependant diabetes mellitus. 
The culture of the BAL fluid samples yielded many different microorganisms (Table 2). 
Filamentous fungi were cultured from two BAL Huid specimens. In one case A. fumigatus 
was cultured, together with Pseudomonas aeruginosa and cytomegalovirus, from a patient 
with agammaglobulinemia, and PCR was also positive. Paecilomyces species were 
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Table 2. Diagnostic yield of 72 BAL fluid specimens and results of Aspergillus genus-specific 
PCR. 
Culture Number of BAL PCR result 
specimens (positive/negative) 
negative 14 1 /13 
Bacteria' 
alone 24 3 / 2 1 
+ Candida spp 13 2/11 
+ virus 3 0 / 3 
+ Pneumocystis carinii 3 0 / 3 
+ virus + Aspergillus fumigatus 1 1 / 0 
+ virus + Candida spp 3 0 / 3 
+ virus + P. carinii 1 1 / 0 
+ virus + Candida spp + P. carinii 1 0 / 1 
+ Candida spp + Paecilomyces spp 1 0 / 1 
Yeasts' 
alone 4 3 / 1 
+ P. carinii 1 0 / 1 
Viruses' 
alone 2 0 / 2 
+ P. carinii 1 0/1 
Total 72 11/61 
"Gram-positive and Gram-negative bacteria, Mycobacterium tuberculosis, Mycobacterium species, 
and Legionella pneumophila; ^Candida albicans, Torulopsis glabrata, C. tropicalis and C. 
lusitaniae; 'Herpes simplex, Cytomegalovirus, Influenza A and Rhinovirus. 
cultured, together with Enterobacter cloacae and Candida albicans, from a sample 
obtained from a patient with a tumor of the hypopharynx, and in this case the PCR was 
negative. Amplification with B-globin primers was performed in order to determine the 
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quality of the isolated DNA and was found to be positive for all cases. An example of the 
PCR results is shown in Figure 1. In some cases nonspecific amplification products were 
visible on agarose gel (Figure 1A, lanes 3 - 5 ) , but no hybridization was found with an 
Aspergillus specific oligonucleotide probe (Figure IB). 
Figure 1. PCR analysis of patients at low risk for invasive aspergillosis. Nucleic acids were 
extracted from BAL fluid samples, subjected to PCR amplification, and analyzed by agarose gel 
electrophoresis (1A) and Southern blot hybridization (IB). Lanes: M, size marker (Hinfl-digested 
pBR322); 1 and 2, BAL fluid sample with positive amplification in both dilutions containing 0.1 
μg and 0.5 pg of DNA respectively; 3 and 4, BAL fluid sample with non-specific amplification in 
both dilutions; 5 and 6, BAL fluid sample with non-specific amplification in the lowest dilution 
(0.1 \ig); 7 and 8, negative BAL fluid sample; 9 and 10, negative BAL fluid sample; + , A.fumi­
gates DNA; -, distilled water. Arrows indicate PCR fragment of 363-bp. 
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Discussion 
The sensitivity of the PCR for the detection of Aspergillus DNA in BAL fluid samples is 
very high, and the DNA content equivalent to two Aspergillus genomes can be detec-
(^ 19,78,97,111,119 since colonization of the respiratory tract with Aspergillus species is 
common, a positive amplification in the case of colonization may be a serious drawback 
for the use of the PCR to diagnose IA. 
Three research groups have thus far reported the use of PCR for the detection of 
Aspergillus DNA in BAL fluid samples7"·*7·"1·119. These studies indicated that PCR 
detection was more sensitive than conventional diagnostic methods and therefore might be 
a valuable adjunct to current laboratory methods to diagnose IA. Two research groups 
have evaluated the PCR assay for a small number of patients at low risk for IA7'·111·119. 
Spreadbury et al. '" have evaluated their PCR assay, which detected only A. fumigatus, in 
BAL fluid samples of seven patients at low risk for IA and found two samples positive. In 
another study119, the same investigators found five positive samples obtained from 28 non-
immunosuppressed patients, and we previously found no positive samples in 14 non-risk 
patients78. In the present study, review of the patient records showed that all patients were 
non-neutropenic, but that several patients could have been at high risk for IA. Patients 
with kidney - or bone-marrow transplantion or patients with AIDS are at high risk for IA 
at certain stages of therapy or disease. A high risk for IA is present in the second and 
third month after kidney transplantation138, during the first four months after bone-marrow 
transplantation96, and in patients with advanced AIDS and low levels of CD4+ lymphocy-
tes30. None of the patients with these underlying diseases met these criteria and were 
therefore regarded to be at low risk for IA. The prevalence of detectable colonization of 
the respiratory tract with Aspergillus species was found to be low: 11 of the 72 samples 
(15%) were PCR positive, which is similar to the prevalence found by others119. The low 
prevalence of respiratory colonization with Aspergillus must be noted when one takes into 
account that humans are continuously exposed to Aspergillus conidia, the conidia are 
small and after inhalation reach the alveoli of the lungs, and Aspergillus species grow 
readily at body temperature. A low prevalence of colonization suggests that after inhalati-
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on, the Aspergillus conidia are effectively removed from the lungs. Animal studies have 
shown that bronchoalveolar macrophages play a central role in the host defense against A. 
fumigatus, and that after intranasal inoculation A. fumigatus conidia are effectively cleared 
from the lungs"2. 
We have also evaluated well known risk factors for colonization of the respiratory tract 
with Aspergillus species. Corticosteroids have been shown to diminish severely the ability 
of bronchoalveolar macrophages to kill A. fumigatus conidia in mice132. Furthermore, the 
growth rate of Aspergillus species in vitro is greatly enhanced by corticosteroids'4. These 
factors could predispose patients treated with corticosteroids to colonization of the 
respiratory tract with Aspergillus species. Smoking of tabacco or marihuana is also 
regarded to be a risk factor for colonization, because Aspergillus species have been 
cultured from these substances37,50. Aspergillus species are frequently isolated from 
respiratory secretions obtained from smokers144, and also elevated precipitins against 
Aspergillus have been found in sera of smokers*3. All but one of the positive Aspergillus 
PCR amplifications were found in samples obtained from patients with risk factors, and 
this confirms the predisposition of these patients for colonization of the respiratory tract 
with Aspergillus species. However, despite the high prevalence of risk factors in the 
patient group which was studied, the prevalence of colonization was found to be low. 
Therefore additional factors such as underlying disease, duration of corticosteroid therapy 
or dosage must play an important role. 
The amount of DNA isolated from the BAL fluid samples, of course, represents mainly 
human DNA. The impact of an excess of background human DNA on the sensitivity of 
the PCR is not clear, but comparitive studies in respiratory secretions have shown no 
influence of excess of background human DNA on the sensitivity120. Since the presence of 
inhibitory factors in the sample could generate false-negative PCR results120, the BAL 
fluid samples were analysed in two dilutions. In most cases, in which a positive amplifi-
cation was found, only the lowest dilution was positive, indicating that inhibition did not 
play an important role, which was also demonstrated by the positive amplification with B-
globin primers. 
Although the specificity of the Aspergillus genus-specific PCR assay is high, specific 
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amplification was found to occur also with Pénicillium mameffei and Paecilomyces 
variotif*. These moulds could be distinguished from Aspergillus species by Southern blot 
analysis with an Aspergillus specific oligonucleotide probe and restriction enzyme 
digestion of the amplification product by StyV*. Indeed, although culture of the presently 
tested BAL fluid specimens yielded many different microorganisms (Table 2), no specific 
amplification of DNA from other microorganisms than Aspergillus species was observed, 
including a non-speciated Paecilomyces. In a number of samples in which no Aspergillus 
DNA was detected, non-specific amplification was observed despite the use of hot-start 
PCR (Figure 1A, lanes 3 - 5 ) . Some of these amplification products were of similar size 
to the 363-bp fragment of the Aspergillus amplification, which makes direct visual 
examination of the agarose-gel sometimes difficult. Southern blot analysis, however, 
showed clearly only hybridization with the Aspergillus positive samples (Figure IB). We 
believe that the excess of background human DNA could account for non-specific 
amplification because, in our experience, BAL fluid obtained from neutropenic patients 
rarely exhibits this phenomenon. This is supported by the fact that the total cell count in 
BAL fluid obtained from neutropenic patients is significantly lower than compared to non-
neutropenic patients26. 
The PCR is a sensitive and specific assay and the use of this technique could contribute to 
the diagnosis of IA in an early stage of the infection. The results of the present study 
indicate that the prevalence of colonization of the respiratory tract with Aspergillus 
species in non-neutropenic patients is low, even in patients with risk factors. However, a 
positive amplification could represent colonization and therefore the PCR results should 
be interpreted in the whole clinical context of the patient. Although the use of the PCR 
for the diagnosis of IA is promising, the diagnostic value can only be assessed in 
prospective studies, and a prospective evaluation of the PCR assay is now being perfor-
med at our institute. 
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GENERAL PRIMER-MEDIATED PCR FOR DETECTION OF 
ASPERGILLUS SPECIES 
W.J.G. Melchers, P.E. Verweij, P. Van Den Hurk, A. Van Belkum, B.E. De Pauw, 
J. Α. Α. Hoogkamp-Korstanje, and J.F.G.M. Meis 
Journal of Clinical Microbiology 1994;32:1710-7. 
Reprinted with permission, ASM Press, Washington, USA. 
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Summary 
A polymerase chain reaction (PCR) assay was developed for the diagnosis of invasive 
aspergillosis in immunocompromised patients. For this purpose, the complete nucleotide 
sequences of the genes encoding the 18S rRNA from Aspergillus nidulans, A. terreus, A. 
mger, and A. flaws were elucidated and aligned to the sequences of A. fiimigatus and 
other clinically relevant prokaryotic and eukaryotic microorganisms. Genus specific 
sequences could be identified in the V7 to V9 region of the 18S rRNA. Using hot-start 
PCR, Southern-blot hybridization and restriction enzyme analysis, Aspergillus specific and 
-sensitive determination was achieved. 
Five of six immunosuppressed mice experimentally infected with A. fumigatus developed 
infection, and rRNA could be detected in each case, even in the livers in the absence of 
positive cultures. Aspergillus species were detected by PCR in four neutropenic patients 
with proven aspergillosis although Aspergillus had been isolated from only one bronchoal-
veolar lavage (BAL) fluid sample. Aspergillus species were detected by PCR in two more 
patients suspected of having infection. Positive PCR signals were obtained from the BAL 
samples of three of eight neutropenic patients who had developed pulmonary infiltrates, 
but none were obtained from the samples of 14 nonimmunosuppressed patients. These 
results indicate the potential value of PCR to detect Aspergillus species in BAL samples 
and, therefore, to identify neutropenic patients at risk for invasive aspergillosis. 
Introduction 
The genus Aspergillus is an ubiquitous saprophytic soil fungus which colonizes the 
respiratory tract in humans24 and is responsible for opportunistic infection in immunocom-
promised patients100·118·134. Indeed, invasive aspergillosis (IA) is responsible for up to 41% 
of the deaths of patients with acute leukemia, and despite the severity and high mortality 
attributable to this mycosis, there has been little progress in accurately diagnosing 
infection ante mortem14·79. While isolation of the fungus from sputum and bronchoalveolar 
lavage (BAL) fluid is indicative of infection, both specimens lack sufficient specificity and 
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sensitivity1181. Although the invasive techniques necessary to obtain a biopsy are usually 
precluded because of profound thrombocytopenia, the histological demonstration of fungal 
elements in tissue is mandatory for proven infection24. Serology has little to offer as an 
alternative since the immune response is desultory and, hitherto, the detection of antigen 
has met with little success. Since successful treatment depends upon intervening before 
fungal proliferation becomes overwhelming1·42 and since there is, as yet, no rapid reliable 
means of diagnosis, therapy is begun empirically, often on the most permissive basis such 
as persistent unexplained fever despite broad-spectrum antibacterial therapy, and continu-
ed until after the recovery of granulocytes. 
Recent studies have described PCR methods for detecting A. fiimigatus and A. flavus in 
clinical material from immunosuppressed patients97,111·119. However, other species can be 
involved24, and so it seemed important to us to ascertain that a patient had infection with 
any Aspergillus organism. We therefore elucidated the complete sequences of 18S rRNA 
of several species of Aspergillus and related fungi and aligned them with sequences from 
other sources. In this way, it was possible to develop a sensitive and specific detection 
assay for the genus Aspergillus which could be validated in experimentally infected mice 
as well as in BAL fluid from patients who were at risk of pulmonary infection. 
Materials and Methods 
Organisms and growth conditions 
Aspergillus fiimigatus (CBS113.26), A. flavus (CBS 108.30), A. nidulans (CBS100.20), 
A. terreus (CBS106.25), and A. niger (CBS102.12) were obtained from the Centraalbu-
reau voor Schimmelcultures (CBS, Baarn, The Netherlands). In addition, a panel of 
micro-organisms was chosen to represent molds related to Aspergillus organisms, 
including two Pénicillium strains, Pénicillium mameffei (AZN 747) and P. chrysogenum 
(AZN 1126), Pseudoallescheria boydii (AZN 409), a Fusarium strain (AZN 441), 
Paecilomyces variotii (AZN 731), and Rhizopus oryzae (AZN 593); the yeasts Candida 
albicans (ATTC 90028), С tropicalis (AZN 393), С krusei (AZN 416), Torulopsis 
(Candida) glabrata (ATCC 90030), and Cryptococcus neoformans (ATCC 90112); as well 
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as the bacteria, Streptococcus sanguis, S. mitis, Staphylococcus aureus (ATCC 25923), 
Pseudomonas aeruginosa (ATCC 10145), Escherichia coli (ATCC 25922), Klebsiella 
pneumoniae (ATCC 10031), and Enterobacter cloacae (ATCC 13047). Clinical isolates 
were identified with standard methods and were assigned a University Hospital Nijmegen 
storage number (AZN-number). 
Sequence analysis of the 18S rRNA genes 
Specific primers of Aspergillus organisms included the 18S rRNA sequence of A. 
fimugatus described by Bams and associates11 and the 18S rRNA from A. flavus, A. 
nidulans, A. niger, and A. terreus which were sequenced by us. 
Mycelial growth was peeled off from the agar surface with sterile forceps, and suspended 
in 600 μΐ of distilled water which had been pretreated with diethyl pyrocarbonate 
(DEPC). This suspension was added to 1 ml of 0.5-mm-diameter zirconium beads which 
had been washed and autoclaved in 0.2% sodium dodecyl sulphate in IM sodium bicarbo­
nate. Complete cell destruction was achieved by high-frequency shaking at 6000 vibrati­
ons per min for 160 sec in a Mini-Beadbeater system (Tecnolab Int., Alkmaar, The 
Netherlands). Next, the mixture was centrifuged for 15 min at 2,500 rpm (Eppendorf 
centrifuge). Nucleic acids were purified by successively phenol, phenol-chloroform-
isoamyl alcohol (25:24:1), and chloroform-isoamyl alcohol extraction74 followed by 
precipitation with ethanol overnight at -20°C and were finally dissolved in 100 μΐ of 
DEPC-treated distilled water which contained 0.4 U of human placental RNase inhibitor 
per μΐ (RNasin, Promega, Leiden, the Netherlands). 
The complete 18S rDNA was amplified by PCR using the general eukaryotic 5' and 3' 
18S rRNA primers 5*-CCTGGTTGATCCTGCCAGTA-3· and 5'-GCTTGATCCTT-
CTGCAGGTT-3', respectively27. PCR was performed in a 100 μί reaction mixture 
containing 10 mM Tris-HCl (pH 9.0 at 25ÔC), 10 mM KCl, 1.4 mM MgCl2, 0.2 mM of 
(each) deoxynucleoside triphosphates (dNTPs), 0.1% Triton X-100, 50 pmol of each of 
the two primers, 0.2 U superTaq DNA polymerase (HT Biotechnology, Cambridge, 
England), and 0.5 μ.% of DNA from each Aspergillus isolate which had been denatured at 
94еС for 5 min. Next, 30 cycles of amplification were performed by denaturating for 1 
34 
Aspergillus detection by PCR 
min at 94°C, annealing the primer for 1 min at 42°С, and allowing elongation for 3 min 
at 72°C. When successful, amplification generated a product of approximately 1800 
basepairs. Each product was analyzed by electrophoresis in 1.5% agarose gels. The 
amplification products required for sequencing were purified from low-melting-point 
agarose (LKB) by the Prep-a-Gene system (BioRad Laboratories). DNA sequencing was 
performed by the dideoxy method108. Annealing of a primer to the template was perfor­
med by heat denaturing double-stranded PCR products in the presence of a primer and 
then immediately freezing them in a C02-cooled ethanol bath. Primers selected from 
several conserved regions of 18S RNA served as sequencing primers. The resultant 
sequences were aligned to those of A. fianigatus and the other organisms detailed earlier 
by a sequence analysis software package (Genetic Computer Group at the University of 
Wisconsin) implemented on a VAX computer, and Aspergillus genus-specific sequences 
were selected and tested for their specificity. Initially, it appeared impossible to distin­
guish Aspergillus organisms from the Pénicillium and Paecilomyces strains. Consequently, 
the 18S rRNA genes of these fungi were also sequenced. Subsequent alignment resulted in 
two primers for the Aspergillus genus-specific PCR assay which yielded a 363 bp 
fragment for positive amplification; Aspi, 5'-CGGCCCTTAAATAGCCCGGTC-3', 
located in the V7 region; and Aspi, 5'-ACCCCCCTGAG-CCAGTCCG-3', located in the 
V9 region of the 18S rRNA (see Figure 1). 
Experimentally infected mice 
Ten CD-I Swiss mice (Central Animal Laboratory, Nijmegen, the Netherlands) were 
immunosuppressed with ISO mg cyclophosphamide (Endoxan-Asta) per kg of body weight 
given subcutaneously three days before and on the day of infection and protected from 
bacterial infection by daily intraperitoneal injections of 40 mg of imipenem-cilastatin 
(Merck, Sharpe & Dohme, Haarlem, the Netherlands) per kg. Six mice were infected 
intranasally with approximately 10* conidia of A. fumigatus under general anaesthesia 
with 0.1 ml of 4.5% chloral hydrate per 10 g of body weight administered intraperitone-
ally while the other four served as controls. Treatment with imipenem was continued until 
four days after infection when the mice were killed and their lungs and livers were 
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removed. The tissues were cut and divided into three portions. The first was used to 
inoculate Sabouraud glucose agar which was then incubated at 42°C for 5 days. A second 
portion was homogenized with disposable pellet pestles and tubes (Kontes, Vineland, NJ) 
in 600 μΐ of DEPC-treated distilled water, after which nucleic acids were obtained as 
described above. The remaining tissue was fixed in buffered formalin (4%), embedded in 
paraffin, and examined for the presence of fungus after ^-aminosalicylic acid staining. 
Clinical samples 
BAL fluid samples were tested retrospectively by the PCR. Eighteen samples of BAL 
fluid had been obtained from 14 neutropenic patients who had developed a variety of 
pulmonary infiltrates during neutropenia induced by treatment for hematological malig­
nancy (Table I). Aspergillosis was proven in four cases and suspected in two cases. As 
controls 14 BAL fluid samples were obtained from patients who were unlikely to be at 
any risk for IA. The BAL fluids were centrifuged at 2,500 rpm in an Eppendorf centrifu­
ge for 15 minutes, and the supernatant was discarded. The residue was resuspended in a 
total volume of 600 μ\ of DEPC-treated water, and nucleic acids were isolated as 
described above. 
Aspergillus culture 
A pellet of BAL fluid was microscopically examined after fluorescent staining (Fungiqual: 
CIBA-GEIGY, Basel, Switzerland), plated on Sabouraud glucose (2%) agar, and cultured 
for 5 days at 28 °C and 42 °C. Histopathological evidence of IA was obtained from 
autopsy material. 
Reverse transcription and hot-start PCR 
rRNA was transcribed into cDNA at 37° С for 60 min in 20 μ\ of reaction mixture of 75 
mM KCl, 50 mM Tris-HCl (pH 8.3), 6 mM MgCl2, 10 mM dithiotreitol, 0.2 mM dNTPs 
(Boehringer GmbH, Mannheim, Germany), 50 pmol of the downstream primer Aspi (see 
above), 5U of avian myeloblastosis virus reverse transcriptase (Promega) and 1 μ% of 
nucleic acid (determined on a GeneQuant apparatus from Bio-Rad). One waxgem (Ampli-
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Wax; Perkin-Elmer Cetus, Leiden, the Netherlands) was added to the sample for PCR 
analysis, heated to 80°C to allow the wax to melt and to cover the surface, and then 
returned to room temperature to allow the wax to solidify. This prevents the nucleic acids 
from melting into the PCR mixture and allows the amplification reaction to start at a high 
temperature, thereby preventing premature annealing and extension of the primer. Eighty 
microliters of the following PCR mixture was then deposited on the surface of the wax: 
50 mM KCl, 10 mM Tris-HCl (pH 8.9), 1.0 mM MgCl2, 0.2 mM (each) dNTPs, 0.1% 
Triton X-100, 80 pmol of the upstream primer Aspi (see above), 40 pmol of the down­
stream primer Asp2, and 0.2 U of SuperTaq DNA polymerase (HT Biotechnology Ltd.). 
RNA-cDNA hybrids were denatured at 94°C for 5 min and then underwent 40 cycles 
consisting of denaturation at 94°C, primer annealing at 62°C, and elongation 72°C, each 
lasting 1 min. The recommendations of Kwok and Higuchi67 were followed and each 
technical step was kept strictly isolated to prevent contamination. 
Analysis of amplified DNA 
Aliquots of 25 μΐ samples were analyzed by electrophoresis on a 1.5% agarose gel stained 
with ethidium bromide74. Before Southern blotting, the agarose gel was depurinated in 
0.25 N HCl, denatured in 0.5 N NaOH-1.5 M NaCl, and transferred to a nylon membra­
ne (Hybond; Amersham Int., Bucks, England) by diffusion blotting in 0.5 N NaOH-
1.5 M NaCl. DNA was covalently bound to the membrane by baking at 80°C for 2 h. 
Membranes were then prehybridized in 6 χ SSC (1 χ SCC consists of 15 mM sodium ci­
trate and 150 mM sodium chloride)-5 χ Denhardt solution (1 χ Denhardt solution consists 
of 0.02% polyvinylpyrollidone, 0.02% Ficoll, and 0.02% bovine serum albumin)-0.1 % 
SDS-250 /tg of denatured sonicated herring sperm DNA per ml at 42° С for 2 h. 
Hybridization was achieved over 16 h at 42°C in 6 χ SSC-lx Denhardt solution-0.1 % 
SDS-100 μg of herring sperm DNA per ml-lC cpm of a 32P-5'-end-labelled Aspergillus-
specific oligonucleotide probe (Asp-p, 5'-ATGGAAGTGCGCGGCAATAAC-3') per ml. 
The blots were washed twice at 42°C in 2 χ SSC-0.1% SDS and once in 0.5 χ SSC-0.1% 
SDS at 55°C, each for 30 min. Kodak Royal X-Omat films were exposed to the blots for 
4 to 8 h between intensifying screens (Dupont) at -80°C to allow autoradiography. 
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Nucleotide sequence accession numbers 
The nucleotide sequence data reported in this paper will appear in the EMBL, GenBank, 
and DDBJ nucleotide sequence data bases under the accession numbers X78537 (A. 
flavus), X78538 {A. niger), X78539 (A. nidulans), and X78540 (A. terreus). 
Results 
Selection of an Aspergillus genus-specific primer set and probe 
The sequence alignment data of the V7 to V9 regions of the rRNA from the different 
Aspergillus species showed extensive homology with those of P. marneffei, P. chrysoge-
num, and Paecilomyces variotii (Figure 1) but not with those of the other microorga-
nisms. One primer which was fully homologous to all Aspergillus species but had a single 
mismatch to P. chrysogenum, P. marneffei, and Paecilomyces variotii (Figure 1) was 
selected from the variable region V7. The other primer selected from the variable region 
V9 was not absolutely conserved for all Aspergillus species and displayed one or two 
mismatches and dispersed variability. P. marneffei contained only one mismatch while 
Paecilomyces variotii was completely homologous (Figure 1). Pénicillium chrysogenum 
contained four mismatches making it unsuitable for hot-start PCR with high-temperature 
annealing. 
The probe finally selected comprised part of the conserved region between the variable 
regions V7 and V8 and was homologous among the Aspergillus isolates and Paecilomyces 
variotii but not P. marneffei, in which the sequence contained two mismatches. A single 
base difference in the variable region V8 between the Aspergillus species and the other 
molds yielded an endonuclease Styl site, thereby permitting endonuclease restriction 
analysis of the amplification products to distinguish the Aspergillus species from Paecilo-
myces variotii (Figure 1). Thus, by using a PCR assay that combines amplification, 
hybridization and endonuclease restriction analysis, it should be possible to specifically 
identify Aspergillus species. 
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Specificity of the Aspergillus genus-specific PCR assay 
Hot-start PCR was performed to exclude nonspecific primer annealing. At an annealing 
temperature of 62°C, specific amplification was observed with all the Aspergillus species 
and also with P. marneffei and Paecilomyces variotii but with none of the other microor­
ganisms, including P. chrysogenum (Figure 2). Southern blot analysis with the internal 
oligonucleotide probe showed clear hybridization with all the Aspergillus species and 
Paecilomyces variotii but not with P. marneffei (Figure 2). To distinghuish Aspergillus 
species from Paecilomyces variotii, 25 μ\ of each amplication reaction was digested with 
Styl (Figure 3) and the amplification product of 363 bp found in each Aspergillus species 
was digested in two fragments of 160 bp and 203 bp, whereas the PCR product of 
Paecilomyces variotii remained intact. 
Sensitivity of the Aspergillus genus-specific PCR 
Serial 10-fold dilutions of purified A. fumigatus nucleic acids isolated from the same 
sample were tested by PCR. Without prior transcription of the rRNA, a sensitivity of 1 
pg of nucleic acid was obtained (on the basis of the DNA content), as detected by gel 
electrophoresis (Figure 4A). However, when the rRNA was first transcribed into cDNA, 
10 fg of nucleic acids was detected on gel (Figure 4B). Southern blot analysis with the 
Aspergillus oligonucleotide probe increased the sensitivity another 10-fold. 
Experimentally infected mice 
A. fumigatus was cultured from multiple foci in the lungs of all six infected mice (mice 1 
to 6, Table II) while the PCR was positive in only five animals (Figure 5). Hyphae were 
also found in the livers, although A. fumigatus was not recovered by culture. PCR on 
liver tissue was positive in each case, although the amplification signal was less intense 
than that obtained from the corresponding lungs (Figure 5). In mouse 2, there was no 
histological evidence for invasive aspergillosis in either the lung or liver, and the culture 
and PCR both proved negative. There was neither histological nor cultural evidence of A. 
fumigatus in any of the lungs and livers from the healthy, immunosuppressed control mice 
(mice 7 to 10, Table II), and the PCR was negative in every case. 
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Figure 1. Sequence alignment and primer selection for Aspergillus genus-specific PCR assay. 1, 
A. fumigatus; 2, A. nidulans; 3, A. niger; 4, A. flavus; 5, A. terreus; 6, Paecilomyces variotii; 
7, Pénicillium chrysogenum; 8, P. marneffei. Aspi, Asp2, and Asp-p represent the regions of the 
Aspergillus primers and probe. Above the sequences, the variable regions V7 to V9 are indicated. 
Styl, the Styl endonuclease restriction site CCT(T/A)GG. 
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M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 M 
Figure 2. Specificity of the Aspergillus genus-specific PCR. PCR with the Aspergillus genus-
specific primer set was performed on a number of different fungal and bacterial species. The 
reactions were analysed by agarose gel electrophoresis (top) and Southern blot hybridization with 
a T-32P-labeled oligonucleotide probe (Asp-p)(bottom). Lanes: M, size marker (Hinfl-digested 
pBR322); 1, A. fumigatus; 2, Candida albicans; 3, C. tropicalis; 4, С. krusei; 5, Candida 
(Torulopsis) glabrata; 6, Pseudoallescheria boydii; 7, Fusarium species; 8, Enterobacter cloacae; 
9, Paecilomyces variotii; 10, Pénicillium chrysogenum; 11, P. marneffei; 12, Cryptococcus 
neoformans; 13, a Rhizopus strain; 14, Streptococcus sanguis; 15, S. mitis; 16, Staphylococcus 
aureus; 17, Pseudomonas aeruginosa; 18, Escherichia coli; 19, Klebsiella pneumoniae; 20, 
distilled water. Arrows indicate PCR fragment of 363 bp. 
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Clinical samples 
Positive amplification was obtained from nine patients, four of whom had proven case and 
two had suspected cases of aspergillosis. An unspeciated Aspergillus species had been 
isolated from one BAL fluid sample from which a strong amplification signal was also 
obtained (patient 1; Figure 6). This patient was one of two who succumbed to IA. The 
other patient (patient 2) died of disseminated aspergillosis, and only Corynebacterium 
jeikeium had been isolated from BAL fluid, although serum samples had been repeatedly 
Figure 3. Analysis of Aspergillus genus-specific PCR fragments. A sample of the PCR mixture was 
digested with Styl. The restriction endonuclease reactions were analysed by agarose gel electrop-
horesis. Lanes: 1, A. rumigarus; 2, A. flavus; 3, A. terreus; 4, A. nidulans; 5, A. niger; 6, 
Paecilomyces variotii; a, PCR control fragment of 363 bp (also indicated by large arrow); b, PCR 
fragments digested with Styl (also indicated by small arrows at 160 and 203 bp, respectively). 
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positive for an Aspergillus antigen (Pastorex Aspergillus, Sanofi Diagnostics Pasteur, 
Mames-La-Coquette, France). Hyphae consistent with Aspergillus species were seen in 
lung biopsy material obtained from patient 3, who had undergone open-lung surgery to 
exclude aspergillosis. Culture of the biopsy remained negative, but PCR was positive for 
Aspergillus species (Figure 6, lanes 4). Three months later, this patient underwent BAL, 
having developed a pulmonary infiltrate during another episode of neutropenia. Cultures 
of BAL fluid were again negative, but PCR remained positive (Figure 6, lanes 5). The 
last patient with proven aspergillosis (patient 4) had initially developed a pulmonary 
infiltrate eight months earlier during remission induction therapy. Candida albicans was 
isolated from the BAL fluid sample, although A. fumigatus had been isolated from oral 
cultures. Then, during a second course of chemotherapy, a cavity developed in the right 
upper lobe consistent with lesions if IA but culture of the BAL fluid was again negative. 
Both BAL fluid samples were found positive by PCR for Aspergillus species. Patient 5 
survived a pulmonary infiltrate suspected to be due to aspergillosis. Herpes simplex virus 
was isolated from the BAL fluid, and only 286 mg of amphotericin В was given as 
therapy when neutrophils recovered. BAL fluid from patient 6 was negative in culture, 
and he survived after being treated with 4 mg of liposomal amphotericin В (Ambisome; 
Vestar Europe) per kg for 36 days. С albicans was both seen microscopically and 
isolated from BAL of patient 7, who ultimately died of her underlying disease. However, 
no autopsy was performed to exclude IA. She had been treated with more than 1 g of 
amphotericin В and had also received fluconazole (400 mg/day) for 15 days. Patient 8 
was suffering from severe graft versus host disease after an allogeneic bone marrow 
transplant. Two BAL fluid samples were available for PCR analysis. The first BAL fluid 
sample had been obtained 20 months after transplant when the patient had developed an 
infiltrate in the right lower lobe. An unspeciated Pénicillium isolate and C. albicans were 
cultured. The patient received a short course of amphotericin В and was given 400 mg 
itraconazole per day as a prophylaxis during the next 8 months. A second BAL fluid 
sample was obtained when no infiltrates were apparent on a chest X-ray. This time, a 
Pénicillium species together with Influenza virus type A was isolated. However, both 
BAL fluid samples were positive by PCR (Figure 6, lanes 2 and 3). 
44 
Aspergillus detection by PCR 
Figure 4. Sensitivity of the detection of diluted purified nucleic acids isolated from A. ftimigatus 
by PCR. The nucleic acid extract either was used directly in the PCR (DNA PCR)(A) or was first 
transcribed into cDNA by reverse transcription prior to the PCR (RNA/DNA PCR)(B). Lanes: M, 
size marker (Hinfl-digested pBR322); 1, 10 ng; 2, 1 ng; 3, 100 pg; 4, 10 pg; 5, 1 pg; 6, 100 fg; 
7, 10 fg; 8, lfg; 10, 100 ag; 11, 10 ag. Arrows indicate PCR fragment of 363 bp. 
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Figure S. PCR analysis of experimentally infected mice. Nucleic acids were extracted from the 
lungs and livers, subjected to PCR amplification, and analysed by agarose gel electrophoresis 
(top) and Southern blot hybridization (bottom). Lanes: M, size marker (Hinfl-digested pBR322); 1, 
lung of mouse 1; 2, liver of mouse 1; 3, lung of mouse 2; 4, liver of mouse 2; 5, lung of mouse 3; 
6, liver of mouse 3; 7, lung of mouse 4; 8, liver of mouse 4, -, lung of uninfected mouse; +, A. 
fumigatus DNA. Arrows indicate PCR fragment of 363 bp. 
The last patient (patient 9) from whom the BAL fluid sample was PCR positive had 
developed bilateral pulmonary infiltrates which resolved following neutrophil recovery 
while completing treatment for acute nonlymphocytic leukemia. All positive samples were 
confirmed to be Aspergillus specific by Styl restriction endonuclease digestion. Samples 
from the five remaining patients were negative by PCR as were those obtained from 14 
nonimmunosuppressed patients. 
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Table 2. Detection of A. fumigatus in organs of experimentally infected mice. 
Detection by 
Mouse Clinical sample Culture Histology PCR 
+ + 
+ + 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
Lung 
Liver 
+ 
+ 
+ 
+ 
+ 
+ 
-
-
-
-
Discussion 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
IA is one of the major clinical concerns in immunocompromised patients because it is 
difficult to detect, even in the case of extensive systemic infections and, treatment appears 
to be successful only when started in an early stage of disease42. While prevention of 
infection remains the ultimate goal, identifying those individuals at greatest risk by a 
rapid diagnosis would provide an alternative since these are most likely to benefit from 
early treatment. Recently, several investigators reported the use of PCR to detect A. 
fumigatus and A. flaws in high-risk patients'7·111,119. However, infection due to other 
species is not uncommon54114, and so it seems important to detect all clinically relevant 
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Figure 6. PCR analysis of patients at risk for invasive aspergillosis. Nucleic acids were extracted 
from BAL fluid samples, subjected to PCR amplification, and analysed by agarose gel electropho-
resis (top) and Southern blot hybridization (bottom). Lanes: M, size marker (Hinfl-digested 
pBR322); 1, Patient 7; 2, Patient 8 BAL fluid sample A; 3, Patient 8 BAL fluid sample B; 4, 
Patient 3 BAL fluid sample A; 5, Patient 3 BAL fluid sample B; 6, Patient 2; 7, Patient 1; 8, 
Patient 4; 9 through 12, BAL fluid samples from control patients; +, A. fumigatus DNA; -, 
distilled water. Arrows indicate PCR fragment of 363 bp. 
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Aspergillus species by developing a genus-specific PCR assay such as we describe. rRNA 
has been used as the target for the development of a species- or genus-specific PCR 
assays for several different microorganisms, such as mycobacteria and mycoplasmas'6124. 
Since only the 18S rRNA of A. fiimigatus had been previously sequenced", we elucidated 
the complete 18S rRNA sequences of the other opportunistic pathogens A. flavus, A. 
terreus, A. nidulans, and A. niger. Alignment of the sequences revealed the impossibility 
of selecting Aspergillus species-specific primers for PCR. However, several domains, 
mainly in the variable regions V7 to V9, which appeared to be Aspergillus genus specific 
were identified. A suitable-looking primer pair was therefore selected from this region, 
but strong cross-hybridization was observed with Paecilomyces variotii, P. marneffei, and 
P. chrysogenum. Spreadbury and colleagues111 also found reactions suggesting a close 
homology between Pénicillium and Aspergillus spp. based on the 26S rRNA sequence. 
Subsequent sequencing of the rRNAs of these fungi showed a close homology to exist 
among the different Aspergillus species. A primer pair from the V7 and V9 region was 
selected (Figure 1), and it was possible to differentiate Aspergillus species from these 
three closely related genera by combining hot-start PCR with high annealing temperature, 
hybridization with a specific oligonucleotide probe, and restriction endonuclease digestion 
with Styl. However, it can not be excluded that other Pénicillium or Paecilomyces species 
or, in fact, other related genera that might be contaminants can be reactive in the assay. 
On the other hand, no specific cross-hybridization was observed with any other prokaryo-
tic or eukaryotic microorganism. Without prior transcription of the rRNA, 1 pg of nucleic 
acids was detected on gel. Sensitivity was increased to 10 fg when the rRNA was first 
transcribed into cDNA, and it was extended 10-fold by Southern blot hybridization. 
However, RNA amplification did not lead to the identification of more positive clinical 
samples than were found by rDNA amplification (data not shown), indicating that 
sufficient sensitivity was obtained without this additional step. Moreover, this provides 
sufficient sensitivity for clinical samples since a single genome of A. nidulans is 
estimated to contain approximately SO fg of chromosomal DNA, based on the karyotype 
of A. nidulans which is equivalent to about 20 fungal elements19. 
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The potential value of the PCR was demonstrated in a mouse model where the PCR was 
positive in five of the six infected immunocompromised mice which had developed IA 
following intranasal inoculation with A. fiimigatus. In contrast to the lung specimens, the 
liver specimens revealed positive PCR signals and histological demonstration of hyphae 
but negative cultures. A possible explanation could be the absence of conidia during the 
growth of A. fiunigatus in liver tissue. Air-containing lung tissue possibly induces better 
sporulation of growing hyphae. None of the control immunosuppressed mice had evidence 
of infection, and each PCR was negative. 
In a clinical setting, a single positive culture of Aspergillus organisms from BAL fluid 
might be indicative for IA81,134 but only multiple samples yield adequate sensitivity144. The 
fungus was isolated from only one of the four patients with IA, although PCR was 
positive in each case. In fact, BAL fluids from nine patients were positive for Aspergillus 
species directly on gel, though infection was either proven or likely in only six cases. 
Although it is possible that the other three patients with a positive PCR test result might 
have had incipient aspergillosis, bronchial colonization cannot be excluded24. Additional 
Southern blot hybridization did not alter the number of patients with positive results, 
suggesting that no more than nine of the 14 patients (64%) who developed pulmonary 
infiltrates during immunosuppression were actually at risk of aspergillosis. Although our 
tertiary care 950-bed University Hospital admits several immunocompromised patients, 
the study of diseases of low prevalence, like IA, will inevitably be limited by the small 
number of patients. The only definitive diagnosis of proven IA is by histopathological 
examination of tissues. In most instances, this is only possible postmortem. Antemortem 
diagnosis is, in our hospital, only possible on BAL fluid and, in most cases, not by open-
lung biopsy because of the associated thrombocytopenia. Therefore, most cases will be 
probable or possible. There is always a possibility of false positivity with this approach. 
However, PCR results should be interpreted in the whole clinical context of the patient 
(e.g., a neutropenic or otherwise immunocompromised patient, treatment with a broad-
spectrum antibiotics, persisting fever, and new infiltrates on chest X ray). We have begun 
to study a larger group of patients to prospectively determine the value of PCR for the 
rapid and early diagnosis of IA. Autopsy surveys have shown that IA developed in around 
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45% of patients who died of hematological malignancy79·124. However, current treatment 
modalities are not without risk, and even though the practice of early empiric therapy is 
fairly widespread53,92, a better determination of the group of patients at risk remains a 
desirable goal. This requires a test with maximum sensitivity, and so it seems appropriate 
to consider any immunosuppressed patient with a BAL fluid sample yielding a positive 
(Southern blot) PCR result as being at risk of IA. We recently used interepeat PCR 
fingerprinting to demonstrate genotypic heterogenicity among A. fumigatus isolates 
originating from different patients and different anatomical locations122. This assay by 
which different isolates can be genotypically characterized can be used in the study of the 
epidemiology of IA. 
In conclusion, the PCR technique we have developed appears suitable to study a large 
group of patients and to identify those at risk of IA. One of the main limitations now is 
that the method itself cannot yet be easily performed in every microbiological laboratory, 
since trained personel and experience with PCR are necessary. However, once validated, 
a method such as ours could have a major impact in reducing the morbidity and mortality 
of patients undergoing treatment for cancer and hematological malignancy by allowing the 
early institution of therapy on a more selective basis than is possible at present. 
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Chapter 2.1 
CLINICAL EVALUATION AND REPRODUCIBILITY OF THE PASTOREX 
ASPERGILLUS ANTIGEN LATEX AGGLUTINATION TEST FOR DIAGNOSING 
INVASIVE ASPERGDLLOSIS 
P.E. Verweij, A.J.M.M. Rijs, B.E. De Pauw, A.M. Horrevorts, 
J.A.A. Hoogkamp-Korstanje, and J.F.G.M. Meis. 
Journal of Clinical Pathology 1995;48:474-6. 
Reprinted with permission, BMJ Publishing Group, London, U.K. 
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Summary 
The performance of Pastorex Aspergillus antigen latex agglutination test for the detection 
of galactomannan in sera of patients at risk for invasive aspergillosis was evaluated, and 
the impact of storage on the reproducibility of the antigen titer was tested. During a one 
year period, 392 serum samples were obtained from 46 patients at risk for invasive 
aspergillosis and tested for the presence of galactomannan using an Aspergillus latex 
agglutination test (Pastorex). Twenty three positive serum samples which had been stored 
at -20°C for 2 - 1 6 months were retrospectively retested. Furthermore, two positive 
serum samples were stored at -20°C and -70eC and prospectively tested at three month 
intervals for a period of 15 months. The Pastorex Aspergillus test was positive in eight 
patients with microbiological, radiological or histological evidence for invasive aspergillo­
sis, but was negative in the initial serum sample of five of these patients. In two patients 
with histological evidence for invasive aspergillosis no positive reaction was found in six 
samples. Six of 13 (45%) serum samples which had been stored at -20°C for six months 
had lost reactivity, while one of 10 (10%) samples had lost reactivity when stored up to 
six months. Two serum samples which had been stored at -20° С and -70° С and prospec­
tively retested at three month intervals for 15 months, maintained stable antigen titers. 
The Pastorex Aspergillus test is too insensitive to diagnose IA in an early stage, but may 
contribute to the diagnosis when cultures remain negative and serial samples are obtained. 
To maintain a good reproducibility, serum samples should be stored at -70°C when the 
period of storage exceeds six months. 
Introduction 
Invasive aspergillosis (IA) is a serious opportunistic infection with a high mortality rate in 
patients with compromised host defences. Since early treatment of IA is associated with a 
reduced mortality rate1, reliable diagnostic tests capable of detecting IA in an early stage 
are of great importance. Early diagnosis is, however, extremely difficult. Therefore tests 
have been developed to detect Aspergillus antigens in body fluids6. Several serological 
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tests to detect antigenemia have been used, including an enzyme linked immunoassay and 
a radioimmunoassay using purified galactomannan102·"7·139. Monoclonal antibodies raised 
against galactomannan114 are the basis of a rapid commercial latex agglutination test 
(Pastorex Aspergillus, Sanofi Diagnostics Pasteur, Mames-La-Coquette, France) on serum 
for detection of circulating antigen. This test, which has been applied in many hospitals, 
yielded sensitivities up to 95% for patients with proven invasive aspergillosis31·44, but has 
been reported to be of limited value because results became negative when testing was 
repeated after storage"137. Here, we report our experience with the Pastorex Aspergillus 
test in patients at risk for IA, and the results of a study we conducted to determine the 
impact of the duration of storage and repeated freezing and thawing on the antigen titer. 
Materials and Methods 
During a one year period, 392 serum samples were obtained from 46 patients at risk for 
IA. At least two serum samples per patient were collected and processed within 24 hours 
of collection, and frozen at -20°C until retesting. Testing of all samples was performed 
by one technician according to the manufacturer's instructions. Titration of positive 
samples was performed by successive twofold dilutions (1:2 to 1:32) in glycine dilution 
buffer. To determine the impact of storage on the antigen titer, all positive serum samples 
were retested retrospectively. 
In addition, a prospective study was performed with two positive serum samples obtained 
from one patient with a histologically proven disseminated infection with A. flavus. The 
impact of repeated freezing and thawing was studied by storing 6 ml of each serum 
sample at -20°C and -70°C, respectively, for a total period of 15 months. At three month 
intervals the samples were thawed and the agglutination reaction was performed. Positive 
agglutination reactions were titrated. The impact of storage on the antigen titer was 
studied by dividing the remainder of the two serum samples into 20 Eppendorf tubes (300 
μΐ). Ten tubes were stored at -20°C and 10 at -70°C for a total period of 15 months. At 
three month intervals two tubes stored at -20°C and two stored at -70°C were thawed. 
The first of each pair of samples was used to perform the agglutination reaction. When 
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positive, the second sample was used for titration. 
The Mann-Whitney test was used to determine statistical significance. 
Results 
A total of 392 serum samples was tested from 46 patients suspected of IA. Seventy serum 
samples were collected from eight patients with microbiological, radiological or histologi­
cal evidence of IA (Table 1). Of these, 24 samples were found to be positive (titers 
ranged from 1:1 to 1:8). In all cases the Pastorex Aspergillus test results were interpreted 
in the whole clinical context of the patient. Antifungal therapy was not given in two cases 
(Table 1, patient Nos 2 and 4). In five cases the antigen test was negative at the time 
antifungal therapy was started, but became positive during treatment (Table 1, patient Nos 
1,3,5,7 and 8). In one case (Table 1, patient No 6) antifungal therapy was initiated when 
the Pastorex Aspergillus test was found positive after five successive samples had been 
negative. Culture of a bronchoalveolar lavage performed the same day yielded A. 
fumigatus. Two patients (acute lymphoblastic leukemia and myelodysplastic syndrome) 
with histologic evidence of IA showed no positive reaction in six samples. 
Table 2. Effect of storage on Aspergillus antigen titer. A: Storage at -20°C and -70"C. Serum 
samples were thawed before every agglutination test. B: Storage at -20°С and -70''C. Serum 
samples were stored untili antigen titer was determined. Serum 1 (SI) and 2 (S2) were taken 3 and 
1 day, respectively, before death due to invasive aspergillosis. 
Time between 
tests (months) 
0 
3 
6 
9 
12 
IS 
SI (-20°C) 
1:8 
1:8 
1:8 
1:8 
1:8 
1:8 
A 
S2 (-70 
1:32 
1:16 
1:16 
1:16 
1:16 
1:16 
Storage 
C) SI (-20 
1:8 
1:8 
1:8 
1:8 
1:8 
1:8 
•C) 
В 
S2 (-70'C) 
1:32 
1:16 
1:16 
1:16 
1:16 
1:16 
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We found only one false positive agglutination in a sample which arrived in the labora­
tory more than 48 hours after collection. Eight other samples from this patient with 
chronic granulomatous disease, processed within six hours of collection, were negative. A 
necropsy performed on this patient, who died of cardiac failure, revealed no evidence of 
IA. 
Twenty-three positive samples, which had been stored at -20°C for 2 - 1 6 months, were 
available for retesting. The results of retesting are shown in Table 1. Nine out of 10 
(90%) positive serum samples, which had been stored up to six months at -20°C, showed 
a positive agglutination reaction when retested retrospectively, while only seven of 13 
(54%) samples were found positive when stored at -20°C for longer than six months 
(Table 1; ρ = 0.067). 
The effect of storage at -20°C and -70°C and of repetitive freezing and thawing of serum 
on the galactomannan antigen titer is shown in Table 2. 
Discussion 
Since serial antigen determination has been shown to be of great importance139, we 
obtained as many serum samples as possible from patients at risk for IA. Several 
investigators have reported the use of a number of methods to detect circulating Aspergil­
lus antigen in body fluids6·64102,117·13'. Although antigen detection appears to be highly 
specific, the sensitivity of the tests used until now has been quite low. The Pastorex 
Aspergillus test is the only antigen test which is commercially avaiable, but its use to 
diagnose IA in an early stage is controversial. Several investigators have reported a high 
sensitivity of this test, up to 95 %31,44, and found that the Pastorex test allowed diagnosis 
of IA to be made earlier in 68% of cases when compared to conventional methods44. 
However, other studies have shown that the Pastorex Aspergillus test had a low sensitivi­
ty22 and a poor positive predictive value7·44 in necropsy proven cases of IA. Our results 
also indicate that the Pastorex Aspergillus test is too insensitive to diagnose IA in an early 
stage, but may contribute in the diagnosis if cultures remain negative and serial serum 
samples are obtained. 
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Poor reproducibility of the Pastorex Aspergillus test has been reported57137, which can 
make the interpretation of positive agglutination results difficult. Warnock et al.137 
retested 10 positive serum samples which had been stored for three days to 10 months at -
30°C, and found that all samples had become negative, and Knight et al." retested 32 
positive samples with a different batch and found loss of reactivity in 14 samples. 
However, these reactions could have been false positive as the manufacturer's instructions 
were not followed115. In the present study, serum samples which had been stored at -20°C 
for more than six months tended to lose reactivity. Although, because of the limited 
number of positive samples available, the difference was not statistically significant in 
comparison to serum samples stored for less than six months, it shows a trend towards 
loss of reactivity when serum samples are stored at -20°C for long periods of time. Also, 
the titer found at retesting tended to be lower when the period of storage became longer. 
The serum samples which were stored at -20°C and -70°C and prospectively retested at 
three month intervals were all found to be positive with stable antigen titers. Repeated 
freezing and thawing of these serum samples (Table 2, A) did not appear to have an 
effect on the reproducibility. However, to maintain a good reproducibility in the Pastorex 
Aspergillus test, we recommend that serum samples should be stored at -70°C when the 
period of storage exceeds six months. 
In the absence of better commercial antigen detection, the Pastorex Aspergillus test 
remains useful although a better test needs to be developed. Other techniques, including 
DNA based assays, may contribute in the diagnosis of IA in an early stage. Several 
investigators have reported the use of the polymerase chain reaction (PCR) for the 
detection of Aspergillus DNA in BAL fluid7»""!»».
 T h e p c R s h o w e d a v e r y n i g h 
sensitivity and specificity in patients at high risk for IA. However, the value of the PCR 
in the diagnosis of this condition remains to be established and prospective evaluations are 
now being performed. The diagnosis of IA is difficult and demands a multidisciplinary 
approach. The implementation and combination of novel or improved methods, for 
example PCR and antigen detection, to diagnose IA in an early stage or in guiding treat-
ment may improve the clinical outcome of this disease. 
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SANDWICH ENZYME-LINKED IMMUNOSORBENT ASSAY COMPARED WITH 
PASTOREX LATEX AGGLUTINATION TEST FOR DIAGNOSING INVASIVE 
ASPERGDLLOSIS IN IMMUNOCOMPROMISED PATDZNTS 
P.E. Verweij, D. Stynen, A.J.M.M. Rijs, B.E. De Pauw, 
J.A.A. Hoogkamp-Korstanje, and J.F.G.M. Meis. 
Journal of Clinical Microbiology 1995;33:1912-4. 
Reprinted with permission, ASM Press, Washington, USA. 
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Summary 
The performance of a direct sandwich enzyme-linked immunosorbent assay (ELISA) for 
detecting Aspergillus galactomannan was compared with that of the Pastorex Aspergillus 
antigen latex agglutination (LA) test by using 332 serum samples from 61 patients at risk 
for invasive aspergillosis. The ELISA gave positive results earlier in the course of infecti-
on than did the LA test. A sensitivity of 70% and a specificity of 86%, were obtained for 
the LA test and corresponding values of 90 and 84% were obtained for the ELISA when 
a series of serum samples was employed. 
Introduction 
Aspergillus fiunigatus is a ubiquitous fungus capable of causing life-threatening opportu-
nistic infections in immunocompromised patients13. Inhalation of airborne Aspergillus 
conidia and germination of spores in the alveoli primarily results in a pulmonary infec-
tion, although dissemination to other organs may occur. The successful diagnosis of 
invasive aspergillosis (IA) is frustrated by the difficulty in obtaining specimens which 
demonstrate the organism directly. Serologic techniques have been used in an attempt to 
establish diagnosis in early stages of infection but have proven to be unsuccessful in 
immunocompromised patients because of the patients' impaired ability to produce a 
humoral response. The detection of circulating Aspergillus antigens in body fluids, e.g. 
serum and urine, is promising, but despite the development of several methods for such 
detection6,64, none has gained widespread acceptance. Recently, a direct sandwich 
enzyme-linked immunosorbent assay (ELISA) has been developed; this assay employs the 
rat monoclonal antibody EB-A2 to detect galactomannan (GM), a cell wall component of 
Aspergillus spp.114,116. The EB-A2 antibody is also used in the commercially available 
Pastorex Aspergillus latex agglutination (LA) test (Sanofi Diagnostics Pasteur, Marnes-La-
Coquette, France)114, but the detection limit can be lowered 10-fold by employing the 
antibody as a captor and detector116, which may allow IA to be diagnosed earlier. We 
investigated this possibilitiy by testing the ELISA with a series of 532 serum samples 
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which had been previously analysed by LA128 to attempt to diagnose IA in 61 immuno­
compromised patients at high risk for the disease. 
Materials and Methods 
A total of 532 serum samples from 61 patients were collected during chemotherapy-
induced neutropenia, and were stored at -80°C. At least two serum samples were 
available from each patient. Before testing, all serum samples were treated as descibed 
previously for Candida marinan" to dissociate immune complexes. The LA tests were 
performed by the same technician exactly as described by the manufacturer. For the 
ELISA, the supernatants of the serum samples were obtained by centrifugating samples at 
15,000 χ g for 10 min. The ELISA was performed as described previously116. Briefly, 50 
μΐ of the treated sample and 50 μ\ of horseradish peroxydase-conjugated EB-A2 were 
placed in the wells of a microtiter plate coated with monoclonal antibody EB-A2, and the 
plates were incubated at 37 °C for 90 min. After the plates were washed, 100 μΐ of buffer 
containing огтЛо-phenylenediamine dihydrochloride was added to the wells, and the plates 
were incubated for 30 min. The reaction was stopped with 50 μΐ 4M sulphuric acid and 
the optical density was read at 492 nm. The optical density of antigen negative serum 
spiked with 1 ng of GM per ml provided the cut-off value116, and a positive and negative 
control were included with each test. 
Results 
The results for the 532 serum samples tested by LA and ELISA are shown in Table 1. A 
total of 325 serum samples were obtained from 33 patients who had a low likelihood of 
IA, i.e., patients for whom there was no clinical, microbiological, histological or radiolo­
gical evidence of infection. Three samples were positive in both tests, two samples 
(1.5%) were positive in the LA test alone, and 22 samples (7.7%) were positive only in 
the ELISA. There was clinical evidence for IA in the other 28 patients, who had all 
developed pulmonary infiltrates and had been febrile (temperatures of > 38°C) for three 
65 
Chapter 2.2 
66 
и 
ц 
" S 
I« 
6 
S. 
ϊ"8 
If 
i 
І 
S 
ІЙ "Π 
h 
li 
g S 
в. V) 
4- ^ 
О О 
β β 
S 
І 
со *•» β ^ 
•- о » п о 
о* «- о* ·-
JO> **. s. Kl oo 
t o •- O 00 ГМ 
irt (* M ГУ 
N O I M m 
S T A 
(я 5 Й 5 
—I —I ш ш ш ш 
II 
d 
>. 
I 
•а 
9 
Í 
25 «*» Я 
И g 
d ьл 
. м 
d э 
Q « 
С 
о 
i| . 
| ° d · 
! » < < £ 
> s S3 о 
1 < t/J 
ι—ι J 
M 
>. 
χι 
8 S. 
s * » 
•α 
ь ¿ у ь. я 
° ° 'м а „ 
·> 9 О Я « 
м
 3
 1 8 3 
I.-S3 8 
1 S a o 
"м e У и 
о · - м <u 
J£\!Q 9
 з-я 
ε 
о 
il 
о 
о 
в 
d 
d 
— - 4» 
*· Ыа (J О 
а І is* 
| | s аа 
л JÇ g 'S 'S 
(Л СЛ Л Ім Іж 
§ • § • § • : § • § 
ε ε ε а 'а 
Eb м ω g о 
'€ 'i S І S 
.s .s .s f * 
з 2 a S S 
d d с 'S 'S 
ω <u <u я « 
•a 'S -s a. D. 
d. 0. 0. < < 
ELISA and latex agglutination for diagnosing invasive aspergillosis 
days despite broadspectrum antimicrobial therapy. For 18 of these patients, the course of 
infection and the results of cultures suggested that IA was unlikely. With the 120 serum 
samples from these 18 patients, positive results were obtained for three samples (2.5%) in 
both tests and 10 samples (8.3%) were positive by ELISA (Table 1). The clinical charac­
teristics of the remaining 10 patients with possible IA (patients showing clinical and 
radiological evidence for IA but having negative culture results) or proven IA (patients 
showing histopathological evidence of tissue invasion at autopsy and having positive 
Aspergillus culture results) are shown in Table 2, together with the results of the analyses 
of 87 serum samples from these patients. GM was not detected by either test in any of the 
serum from patient 1, who had a proven infection. Very low levels of GM in serum, due 
to limited fungal invasion of the pulmonary blood vessels or the release of low levels of 
GM by the fungus into the body fluids, may have contributed to the false-negative result 
for this patient. For the entire patient population, the sensitivity and specificity of the LA 
test were 70 and 86%, respectively, and the sensitivity and specificity of the ELISA were 
90 and 71%, respectively. When a true-positive result for the ELISA was defined as two 
consecutive positive serum samples, the sensitivity was similar (90%) but the specificity 
increased to 84%. 
Discussion 
Diagnosing IA at an early stage of infection is difficult. The culture of Aspergillus species 
from the sputa or bronchoalveolar lavage fluids of patients at high risk for IA is highly 
indicative of infection, but the diagnostic reliability of culture is low81. Therefore, more 
sensitive methods, such as PCR78·97·111·119 and Aspergillus antigen detection7·31·44·47·57·64·75·114-
ш,із7( gjg u n c i e r investigation. The detection of GM by the Pastorex Aspergillus LA test 
has been evaluated at several institutes7'31·44·47·57·75·12'·137, and the test showed sensitivies of 
up to 95% with serum samples from patients with a high index of suspicion for IA31,44. 
The LA test was also found to yield positive results earlier than conventional tests for 
68% of patients with proven IA44. However, these observations were not confirmed by 
others7·47,57·75·128·137, and a sensitivity of only 38% has been reported75. In our study, the 
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LA test yielded positive results only during advanced stages of infection in most patients 
with suspected IA and did not attribute to an earlier diagnosis128. The present study sho-
wed that the ELISA detected GM in serum up to five days earlier than the LA test did. 
Although both LA and ELISA failed to detect one proven infection, the ELISA detected 
GM in two additional patients for whom the LA test continued to yield negative results. 
Moreover, GM was detected by ELISA in more serum samples by ELISA than by LA. 
This suggests that monitoring sequential serum samples from high-risk patients during 
neutropenia may allow the diagnosis of IA to be made at an earlier stage of infection. 
The increased sensitivity of the ELISA, however, was associated with an increase in 
false-positive results. A rate of 8% false positives by ELISA has been found by others"6. 
Therefore, in order to identify a genuine elevation of the GM level in serum, positive 
ELISA results should be found in at least two consecutive serum samples. 
Our results suggest that antigen detection at regular intervals by the sandwich ELISA may 
allow the early diagnosis of IA in immunocompromised patients. Twice-weekly collection 
and testing of serum samples from a patient during the period of neutropenia should be 
sufficient to detect an increase in the GM level in serum early in the course of infection. 
In the case of a positive ELISA result, the collection and testing of serum samples should 
be continued in order to exclude the possibility of a false-positive result. Furthermore, 
confirmation of suspected IA should be obtained by chest roentgenogram, computer 
tomography, or bronchoalveolar lavage. Prospective studies following these guidelines are 
needed to establish the clinical value of this new ELISA. 
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Summary 
The performance of a sandwich enzyme-linked immunosorbent assay (ELISA) which 
detects Aspergillus galactomannan (GM) was evaluated in bronchoalveolar lavage (BAL) 
fluid samples from 19 patients who were treated for hematological malignancies and who 
were suspected of having invasive pulmonary aspergillosis (IPA). All patients had fever 
and pulmonary infiltrates on the chest roentgenogram on the day that the BAL fluid was 
obtained. The ELISA results were compared with the results of culture and Aspergillus 
genus-specific PCR analysis of BAL fluid samples. ELISA was also performed with 
serum samples. Aspergillus species were detected by PCR or ELISA with BAL fluid 
samples from five of seven patients who had radiological evidence of IPA. Serum ELISA 
results were positive for all patients with ELISA-positive BAL fluid, and for four patients 
the serum ELISA was positive before the BAL fluid was obtained. PCR and ELISA were 
positive for 2 and 1 of 10 BAL fluid samples, respectively, obtained from patients 
without radiological evidence of IPA, and 5 and 2 of 35 BAL fluid samples, respectively, 
obtained from nonneutropenic patients. This preliminary investigation suggests that GM 
may be detected by ELISA in BAL fluid samples from patients at risk of IPA, but that 
monitoring of serum GM levels may allow for the earlier diagnosis of IPA. However, 
further evaluation in prospective studies is required. 
Introduction 
Invasive pulmonary aspergillosis (IPA) is a major threat to leukemic patients with 
cytotoxic therapy-induced neutropenia and transplant recipients receiving high-dose 
corticosteroid therapy. Since the diagnosis of IPA in an early stage is seldom possible and 
the mortality rate is very high14, successful treatment is directly related to early diagno­
sis1. Several methods for obtaining an early and rapid diagnosis of IPA are now under 
study. Aspergillus DNA can be detected in bronchoalveolar lavage (BAL) fluid by PCR" 
7в,»7,и9,ш) jjUt m e numbers 0f patients and controls tested have been too limited to 
establish the diagnostic value of this technique. An alternative approach is to detect 
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circulating Aspergillus antigen in body fluids, e.g., serum or urine, by a number of in-
house methods64·101,102. The Aspergillus antigen test (Pastorex Aspergillus, Sanofi Diagnos-
tics Pasteur, Mames-La-Coquette, France) is commercially available and uses the rat 
monoclonal antibody EB-A2 to detect galactomannan (GM), a polysaccharide antigen of 
Aspergillus species*9. This antigen test has been evaluated in several institutes7,44·47·12'137, 
but it has been found to lack sufficient sensitivity44,47,128,137. A recently developed sandwich 
enzyme-linked immunosorbent assay (ELISA) allowed the detection of low levels of 
circulating Aspergillus GM in sera from patients at high risk of IPA, but the increase in 
sensitivity was also associated with false-positive results in up to 8% of the serum 
samples116,129. Since IPA is predominantly a pulmonary infection in immunocompromised 
patients, and Aspergillus fumigatus is known to release GM into the culture medium when 
it is grown in vitro69, detectable antigen levels may be present in BAL fluid samples from 
patients suspected of having IPA and therefore may be of use for the diagnosis of IPA. 
We therefore investigated the use of the sandwich ELISA to detect GM with BAL fluid 
samples which had been collected from patients at high risk and from patients at low risk 
of IPA. The results were compared with those obtained by culture and Aspergillus genus-
specific PCR amplification and were related to the clinical outcome. 
Materials and Methods 
Patients 
During a 12 month period 19 consecutive BAL fluid samples had been collected from 
patients who were neutropenic as a result of cytotoxic therapy or from whom circulating 
granulocytes were recovered. In each patient a bronchoscopy was performed because 
fever (temperature, > 38.3°C) persisted despite treatment with broad-spectrum antibacte-
rial agents and pulmonary infiltrates developed on the chest roentgenogram. The BAL 
fluid sample was obtained by wedging a flexible bronchoscope in the area of maximal 
roentgenographic involvement, after which 150 ml of sterile 0.9% saline was instilled and 
approximately 100 ml was recovered by suctioning. The medical, histopathological, 
microbiological, and radiological records of all patients were reviewed for evidence of 
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IP A or other respiratory disease. Since a definitive diagnosis of IPA is very difficult to 
establish in this patient group, the patients were allocated to three categories by review of 
the appearance of the pulmonary infiltrates on the chest roentgenogram by two physicians 
who were blinded to the medical histories of the patients. The patients were allocated to 
one of the following groups: A, probable IPA (n = 7), with the chest roentgenogram 
showing focal nonanatomical infiltrates or any cavitating lesion; C, unlikely IPA (n=10), 
with the chest roentgenogram showing diffuse infiltrates characterized by nodular, 
reticular, or reticulonodular lesions which were distributed throughout both lung fields or 
anatomical focal infiltrates73; and B, possible IPA (n=2), which included patients with 
infiltrates on the chest roentgenogram who could not be classified into group A or C. Of 
course, the reliability of these definitions is limited because the roentgenographic pattern 
is not always specific for the infectious etiology of the infiltrates. Furthermore, 35 BAL 
fluid samples were collected from nonneutropenic patients who were at low risk for IPA. 
Sample collection 
BAL fluid samples were routinely examined for the presence of bacteria, viruses, fungi, 
and parasites. A total of 5 to 10 ml of each sample was stored at -80°C until analysis by 
ELISA and PCR. The microbiological records were reviewed for serum samples which 
had been collected from each patient between 6 weeks before and 2 weeks after the BAL 
fluid sample was obtained. These samples had also been stored at -80°С until testing by 
ELISA was performed. 
Aspergillus Culture 
Routine culture for fungi was performed after centrifugation of the BAL fluid sample at 
1,500 χ g for 10 min. The pellet was plated onto Sabouraud glucose (2%) agar and was 
cultured for 5 days at 28°C and 48"C. Aspergillus species were identified by one 
technician (A.J.M.M.R.) by their cultural characteristics and the morphologies of their 
conidiophores and conidia. 
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PCR amplification 
After thawing, the BAL fluid samples were centrifugea at 1,500 χ g for 10 min. The 
supernatant was separated from the pellet, leaving a residue of 0.5 ml in which the pellet 
was resuspended. PCR analysis was performed as descibed previously78177. Briefly, high 
frequency shaking was performed to achieve complete cell destruction; this was followed 
by purification of nucleic acids by guanidium thiocyanate-containing lysis buffer and silica 
particles. A hot-start PCR was performed using two Aspergillus genus-specific primers. 
This PCR assay can detect a wide range of the Aspergillus species involved in human 
disease specifically when it is combined with Southern blot hybridization and restriction 
enzyme analysis78. 
ELISA 
The sandwich ELISA used to detect Aspergillus GM in serum samples and BAL fluid 
supernatants was performed exactly as described previously116. Saline 0.9% and culture-
and PCR-negative BAL fluid supernatants from patients at low risk of IPA containing a 
range of dilutions of GM (range: 0.25 to 10 ng/ml) and a negative control BAL fluid 
were included in each test. All serum and BAL fluid samples were tested in duplicate by 
one technician who was unaware of the clinical data. The microtiter plates were prepared 
by the manufacturer (Sanofi Pasteur Diagnostics), and the coating conditions of the plates 
are proprietary. However, since the coating conditions of the EB-A2 monoclonal antibody 
on the microtiter plate were different from those reported previously116, lower optical 
density values were found. 
Results 
Aspergillus ELISA 
Different concentrations of GM (range: 0.25 to 10 ng/ml) were added to 0.9% saline and 
culture- and PCR-negative BAL fluid samples from low-risk patients and were analyzed 
by ELISA. The degree of increase in the optical density values of 0.9% saline spiked 
with increasing concentrations of GM was directly proportional to that found with culture-
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and PCR-negative BAL fluid samples spiked with the same concentrations of GM (data 
not shown). The mean optical density values of the 30 BAL fluid samples from nonneu-
tropenic patients with negative fungal culture and PCR results were used to study the 
ELISA background. There was a Gausian distribution of the optical density values, 
allowing a cutoff value of 0.17 to be calculated from the mean optical density value 
(mean optical density value, 0.09; range, 0.0S6 to 0.146) plus 4 standard deviations. The 
optical density of control serum spiked with 1 ng of GM per ml was used as cutoff value 
for serum (optical density value, 0.17)116. The results of Aspergillus genus-specific PCR 
and ELISA for the BAL fluid samples from 19 patients with hematological malignancies 
and the BAL fluid samples from 35 control patients are given in Table 1. 
Clinical data 
The characteristics of the 19 patients with hematological malignancies and the results of 
culture, PCR, and ELISA are given in Table 2. Five of seven BAL fluid samples from 
patients with probable IP A were positive by PCR and ELISA. GM was detected in serum 
samples from all patients with an ELISA-positive BAL fluid sample. Moreover, serum 
samples were available from the period before the bronchoscopy was performed for four 
patients, and GM could be detected up to 30 days before the BAL fluid sample was 
obtained (patient A5; Table 2). 
Table 1. Results of Aspergillus genus-specific PCR amplification and sandwich ELISA of BAL 
fluid samples obtained from 19 patients with hematological malignancies and 35 nonneutropenic 
patients. 
Microbiological analysis No. of patients 
result 
Hematologic patients Nonneutropenic patients 
PCR positive, ELISA positive 5 0 
PCR positive, ELISA negative 3 5 
PCR negative, ELISA positive 2 2 
PCR negative, ELISA negative 9 28 
Total 19 35 
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Shortly after bone marrow transplantation during severe neutropenia, patient AS develo­
ped fever and sinusitis. The administrationof ciprofloxacin and amoxicillin-clavulanic acid 
did not result in clinical improvement, and amphotericin В (1 mg/kg of body weight per 
day) was added to the regimen. During recovery of the granulocytes, a chest-roentgeno-
gram showed the development of a nodular infiltrate. Although culture of sinus aspirate 
and BAL remained negative, PCR and ELISA of BAL fluid samples were positive, and 
GM was retrospectively detected in the serum at the time that the sinusitis first became 
apparent. 
Both PCR and ELISA were positive for one of two BAL fluid samples from patients with 
possible IPA, but serum samples were not available for analysis by the ELISA. The PCR 
was positive for BAL fluid samples from patients CI and C2, who had no evidence of the 
presence of IPA, and GM was not detected in the BAL fluid or serum samples from these 
patients. GM was detected in a PCR-negative BAL fluid sample from patient C3, and two 
of seven serum samples were also found to be positive. The two ELISA-positive serum 
samples were obtained on the day that the BAL was performed and 1 day thereafter, 
respectively. Five consecutive serum samples obtained during 2 weeks following the BAL 
were all negative, even though severe neutropenia persisted and at the time of the 
seroconversion only a loading dose of 10 mg of amphotericin В had been administered. 
Treatment with ciprofloxacin and amphotericin В (1 mg/kg/day) for 2 weeks resulted in 
resolution of the pulmonary infiltrates. 
Nonneutropenic patients 
PCR analysis of 35 BAL fluid samples from nonneutropenic patients revealed positive 
amplification reactions for five samples which were all negative by ELISA127. The ELISA 
was positive for 2 of 30 PCR-negative BAL fluid samples (Table 1). 
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Discussion 
The diagnosis of IPA in an early stage of the disease is of great importance since early 
antifungal treatment is associated with an improved outcome1. The early diagnosis of IPA 
is difficult, and a definitive diagnosis is often made at autopsy. The presence of severe 
thrombocytopenia in neutropenic patients limits the use of invasive diagnostic procedures 
to obtain a specimen for culture and histopathological examination. BAL has been 
advocated as a safe procedure to obtain a specimen for the diagnosis of IPA in immuno-
compromised patients with pulmonary infiltrates. Although the recovery of Aspergillus 
species from BAL fluid is highly indicative of IPA, the diagnostic yield from culture of 
BAL fluid samples is only 30%126. Therefore, attention has focussed on other techniques 
for the early diagnosis of IPA, such as Aspergillus-speciñc PCR in BAL fluid"·78'7·119 and 
the detection of circulating Aspergillus antigen in serum or urine7·44·47·64·101·102·11*·12»·137. 
Little is known about the utility of Aspergillus antigen detection in BAL fluid. One 
research group has previously described the use of a radioimmunoassay to detect an 
uncharacterized purified A. fitmigatus carbohydrate in BAL fluid4,5,140. The radioimmuno-
assay detected Aspergillus antigen in 91% of the BAL fluid samples from rabbits with 
IPA, and in 27% of these animals antigen was detected in BAL fluid only and not in 
serum4. The radioimmunoassay was also used to detect Aspergillus antigen in BAL fluid 
samples from nine immunocompromised patients with pulmonary infiltrates, and two 
patients were found to be positive5. GM was detected by a latex agglutination test 
(Pastorex Aspergillus) in BAL fluid samples from three patients with AIDS and IPA72. 
However, GM could not be detected by the same test under laboratory conditions in BAL 
fluid samples from 14 untreated rabbits with IPA, while serum samples from 10 (71%) 
animals were positive3'. Although the present study was limited by the difficulty in 
reliably classifying patients with IPA, GM was detected by sandwich ELISA in BAL fluid 
samples from five of seven patients with radiological evidence of IPA, and therefore, this 
test may be promising for use in the diagnosis of this infection. 
The increase in the level of sensitivity required to diagnose early IPA, however, is 
hampered by an increase in the number of false-positive results. For this reason, it was 
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interesting to compare DNA and GM detection, since these two assays have a different 
target. In the case of diagnosis by PCR, a positive result obtained from the use of a BAL 
fluid sample can be due to the presence of contaminating conidia without any mycelial 
development (see, for example, data for patients CI and C2). Indeed, previous studies 
found a rate of 15% positive PCR amplification in BAL fluid samples from nonneutrope-
nic patients11'127. The occurence of a negative PCR result for patient A6, whose BAL 
fluid and serum samples were and who had radiological and clinical evidence of IPA, 
could be due to the presence of inhibitors of the PCR reaction in the BAL fluid120. 
False-positive results were also obtained by the sandwich ELISA. The reasons for the 
false-positive reactions are unknown, but it has been shown that molecules which are 
responsible for the false positivity appear to mimic the epitope recognized by anti-GM 
monoclonal antibodies11'. In 30 culture- and PCR-negative BAL fluid samples from 
nonneutropenic patients, a 7% false-positive rate was found, which is similar to the 8% 
false-positive rate found in serum11*. A 10-fold concentration of the samples by acetone 
precipitation resulted in a false-positive rate of 27% (data not shown). Analysis by PCR 
and ELISA can be done in less than 24 h (PCR, 24 h; ELISA, 4 h), and the results can 
be forwarded to the clinician on the day following the BAL. 
An excellent correlation was found between serum and BAL fluid ELISA results, and GM 
was detected in the serum even before the BAL was performed. Since a bronchoscopy 
was performed only after pulmonary infiltrates were present on the chest roentgenogram, 
GM may be detectable in the serum before infiltrates become visible on the plain chest 
film. It is has been shown that in neutropenic patients abnormalities are difficult to detect 
on plain chest film87 and that other radiologic methods, such as high resolution computed 
tomography, are more sensitive for the detection of pulmonary infiltrates in these 
patients61·*2 and may even be used for therapeutic monitoring136. 
This preliminary investigation suggests that both Aspergillus genus-specific PCR and 
sandwich ELISA might be beneficial for use in the early diagnosis of IPA in patients with 
hematological malignancies. The ELISA is relatively easy to perform, and the results are 
available within 4 h. Since false-positive results may be found by ELISA of the serum, 
detection of Aspergillus species in BAL fluid by ELISA or PCR may provide additional 
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evidence for the presence of IPA. The results of the present study also suggest that in 
some patients GM antigenemia may be detected in serum before pulmonary infiltrates are 
visible on the chest roentgenogram. However, carefully designed prospective studies need 
to be performed in order to evaluate the diagnostic value of these assays. We are 
prospectively monitoring serum GM levels by ELISA in patients during cytotoxic therapy-
induced neutropenia. When GM is detected for the first time, confirmation is sought by 
ELISA with additional serum samples, high-resolution computed tomography scan, and 
where possible, bronchoscopy and PCR analysis of BAL fluid. Once the presence of GM 
is confirmed or the signs or symptoms pathognomonic for IPA have developed, treatment 
with antifungal agents is started preemptively. By following these guidelines, the 
diagnosis and treatment of IPA may be possible at an early stage of infection. 
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Summary 
The performance of an immunoperoxidase stain which employs the monoclonal antibody 
EB-ΑΙ to detect Aspergillus species in formalin-fixed, paraffin-embedded tissue was 
evaluated. The monoclonal antibody EB-ΑΙ directed against galactomannan was used to 
detect Aspergillus species in 23 patients with suspected or proven invasive aspergillosis. 
Immunostaining was performed on formalin-fixed paraffin-embedded tissue using the 
streptavidin-biotin method and compared to conventional hematoxylin and eosin, periodic 
acid-Schiff, and Gomori methenamine silver stain. Results of immunostaining were semi-
quantitatively analyzed with regard to both intensity of staining and number of positively 
staining microorganisms. Tissue sections from 16 patients with proven invasive mycoses 
due to Candida species, Apophysomyces elegans, Rhizopus oryzae, Pseudallescheria 
boydii and Histoplasma capsulatum were used as controls. In 19 out of 23 cases invasive 
aspergillosis was proven by both histological examination and culture (18x Aspergillus 
fianigatus and lx A. flavus). Immunoperoxidase stains were positive in 17 cases (89%) 
including one case of disseminated infection due to A. flavus. Furthermore, the 
immunoperoxidase stain was positive in a culture negative tissue section with histological 
evidence for mycelial development, indicating the presence of Aspergillus species. Some 
cross-reactivity was observed with the highly related fungus P. boydii, although the 
number of mycelial elements staining was low. In general, detection of microorganisms 
with the conventional methods was more difficult than after immunostaining. 
Immunoperoxidase staining using the monoclonal antibody EB-ΑΙ performs well on 
routinely processed tissue sections and allows detection and generic identification of 
Aspergillus species. An additional advantage is that it may help to provide an etiological 
diagnosis when cultures remain negative. 
Introduction 
Aspergillus species can cause severe pulmonary infections in immunocompromised 
patients13. The antemortem diagnosis of invasive aspergillosis is difficult and, although 
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new sensitive diagnostic methods are being evaluated78116130, a definitive etiological 
diagnosis can be made only by the demonstration of tissue invasion by fungal mycelium 
and a positive culture with morphological identification of Aspergillus species. The 
diagnosis of invasive aspergillosis by histological examination of tissue sections alone is 
not reliable, because numerous filamentous fungi cannot be differentiated from 
Aspergillus organisms on morphological criteria. However, a correct etiological diagnosis 
is important for the correct antimycotic therapy of systemic mycoses and for the study of 
fungal epidemiology. Furthermore, the necessity for an etiological diagnosis will increase 
as new fungal pathogens, such as Altemaria species3-142, have been reported to cause 
invasive infections in immunocompromised patients. To obtain a rapid and accurate 
generic identification, both poly-" and monoclonal'·58·'0,89 antibodies have been employed 
for direct immunoperoxidase staining of tissue sections. Previous observations suggested 
that the monoclonal antibody EB-ΑΙ directed to galactomannan was useful in the 
diagnosis of infections resulting from Aspergillus species9. In this study we have evaluated 
the performance of this monoclonal antibody to detect and identify Aspergillus species in 
tissue sections obtained from patients with invasive mycoses. 
Materials and Methods 
Between 1989 and 1991 pathology and microbiology records from the University Hospital 
Nijmegen were reviewed for consecutive autopsy cases with invasive aspergillosis. In 
each case identified, the medical records were reviewed for clinical and radiologic 
evidence of invasive aspergillosis. In addition, tissue sections were obtained from cases 
with proven invasive infections due to other filamentous fungi and Candida species, in 
order to evaluate the specificity of the immunoperoxidase stain. 
All tissue specimens were fixed in 10% formalin solution, and processed through 
paraffin. Four μιυ paraffin sections were cut for conventional stain techniques including 
hematoxylin and eosin (H&E), periodic acid-Schiff (PAS), Gomori methenamine silver 
(GMS), and immuno-histochemistry. Immunohistochemical staining was performed with 
the streptavidin-biotin-peroxidase-complex method. In short, sections were cut and 
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rehydrated, endogenous peroxidase activity was blocked (by incubation in 1% HjOJ, after 
which sections were incubated for 20 minutes in normal goat serum (diluted 1:5 in 
phosphate-buffered saline; PBS). The slides were then incubated with 20 /ig/ml of the 
primary antibody (EB-ΑΙ, Eco-Path Aspergillus, Sanofi Pasteur Diagnostics, Genk, 
Belgium) for 60 minutes at room temperature. As a detection system, we used Multilink I 
(BioGenex, San Ramon, California, USA) followed by streptavidine-peroxidase conjugate 
(BioGenex). As a chromogen, we used a diaminobenzadine solution containing 0.65% 
imidazol. The staining was intensified by incubation in 0.5% CuS04 and 0.9% NaCl for 5 
minutes. Finally, sections were weakly counter-stained with Mayer's hematoxylin, 
dehydrated and mounted. As a negative control, sections were incubated with PBS instead 
of the primary antibody. 
Tissue sections were examined for the presence of the characteristic brown staining and 
semiquantitatively evaluated by estimating the number of stained mycelial elements in the 
following categories: no staining and only a few scattered positive elements (less than 
5%) was considered negative (-), staining 5% to 25% of elements (+), staining in 25 to 
50% ( + + ) , staining in 50% to 75% (+ + +), and staining in 75% to 100% (+ + + +). 
The intensity was graded on a scale of negative to + + + , (-) indicated absence of 
staining; mild staining (+); moderate staining ( + + ) ; and intense staining (+ + +). 
Equivocal reactions were considered negative. Furthermore, any background staining 
including aspecific staining of cells or tissues was noted seperately. All slides were scored 
independantly by two of the authors (P.V., F.S.) 
Results 
A total of 40 tissue sections from 39 patients with either suspected or autopsy proven 
invasive fungal infection were studied. The anatomic sites of fungal infection and the 
results of histologic examination and culture are listed in Table 1. Twenty-three patients 
had either a proven or suspected infection with Aspergillus species. The clinical 
characteristics of these patients and the results of culture and immunoperoxidase staining 
are shown in Table 2. 
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Table 1. Histologie findings, microbiological identification, number of cases and sites of 
involvement of invasive Aspergillus infection in 23 autopsy cases and 16 controls. 
Histologic findings 
mycelial elements 
mycelial elements 
mycelial elements 
negative 
pseudo hyphae 
mycelial elements 
mycelial elements 
yeast form 
Culture 
Aspergillus Jumigatus 
A. flavus 
negative 
A. fumigatus 
Candida spp.* 
Zygomycetes'' 
Pseudallescheria boydii 
Histoplasma capsulatum 
Number 
of cases 
18 
1 
1 
3 
12 
2 
1 
1 
Sites of infection 
diss. 6; lung 12 
diss. 
lung 
lung 
diss. 6; lung 5; tongue 1 
lung 1; humerus 1 
lung 
diss. 
'including C. albicans (10 cases), С tropicalis (one case), and C. parapsilosis (one case), 
'including Apophysomyces elegans and Rhizopus oryzae. 
In 19 of 23 cases there was evidence of disease based on histopathology and culture, 
including seven cases of disseminated infection (cases 1 to 7). All tissue sections obtained 
from the cases with disseminated infection showed intense hyphal immunostaining 
(+ + + +/+ + + , Figure 1A), including one case of A. flavus infection (case 7, Figure 
1С). One patient (case 8) with acute myeloblasts leukemia died of respiratory 
insufficiency, and invasive pulmonary aspergillosis was diagnosed at necropsy. The 
presence of Aspergillus species was confirmed by both culture and immunoperoxidase 
stain. However, in this patient histologic examination of a pulmonary thrombus revealed 
mycelial elements. Culture yielded Rhizopus microsporum var rhizopodiformis and the 
immunostaining was negative. Another patient (case 11) with chronic myeloid leukemia 
died of septicemia and respiratory insufficiency. At autopsy a bronchopneumonia was 
diagnosed in the lower lobe of the left lung with mycelial elements in the GMS stain. 
Although cultures remained negative, the immunostaining indentified Aspergillus species. 
A total of 18 out of 20 (90%) tissue sections with mycelial development were positive by 
the immunoperoxidase method. In three patients (cases 21 to 23) a bronchopneumonia 
was diagnosed at autopsy but, although culture of the lung tissue yielded A. fumigatus, 
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ТаШ 2. Clinical characteristics of 23 patients with invasive aspergillosis and results of culture 
and immunohistochemistry. 
Case Sex/Age Underlying disease Aspergillus 
Infection 
Culture Immuno-
pcroxidase 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
M/41 
M/51 
F/1.5 
F/66 
M/72 
F/45 
F/29 
M/60 
F/15 
M/S8 
M/Sl 
M/32 
M/59 
F/15 
M/ll 
M/57 
M/60 
M/58 
F/44 
M/29 
M/61 
M/55 
M/50 
Myclodysplastic syndrome 
ALL 
Pearsons' Syndrome 
Grawitz tumor 
AML 
AML, BMT 
SLE 
AML 
Agammaglobulinemia 
AML 
CML 
AML 
Adenocarcinoma lung 
NHL. BMT 
CGD 
Hepatocellular carcinoma 
Myelodysplastic Syndrome 
AML 
AML, BMT (2x) 
AML 
HL 
Rheumatoid arthritis, 
Kidney transplant 
AML 
Diss 
Diss 
Diss 
Diss 
Diss 
Diss 
Diss 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
lung 
Aspergillus fianigatus 
A. fianigatus 
A. fianigatus, С albicans 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. ftavus 
A. fianigatus, Rhizopus mi-
crosporon var rhizopodiformis 
A. fianigatus 
A. fianigatus 
negative 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
A. fianigatus 
+ + + +/+ + + 
+ + + +/+ + + 
+ + + +/+ + + 
+ + + +/+ + + 
+ + + +/+ + + 
+ + + +/+ + + 
+ + + +/+ + + 
+ + + +/+ + + 
+ + + +/+ + + 
+ + +/+ + + 
+ + +/+ + + 
+ + +/+ + + 
+ + +/+ + + 
+ + +/+ + + 
+ + + +/+ + + 
+ + +/+ + + 
+ + +/+ + + 
+ + + +/+ + + 
ALL, acute lymphoblastic leukemia; AML, acute myeloblasts leukemia; BMT, bone marrow 
transplantation; SLE, systemic lupus erythematodes; CML, chronic myeloid leukemia; NHL, non-
Hodgkin lymphoma; CGD, chronic granulomatous disease; HL, Hodgkin lymphoma. 
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mycelial elements could not be detected by conventional fungal staining. In all three cases 
the immunostaining was also negative. 
The cross-reactivity of the monoclonal antibody EB-ΑΙ was tested by staining tissue 
sections obtained from 16 patients with поп-Aspergillus mycoses (Table 1), including 12 
histopathological and culture proven cases with invasive candidiasis (C. albicans, 10 
cases; С tropicalis, one case; and С parapsilosis, one case), a patient with pulmonary 
pseudallescheriasis113, a patient with Apophysomyces elegans osteomyelitis of the humeral 
bone77, a patient with a Bhizopus oryzae bronchopneumonia, and a patient with a 
disseminated Histoplasma capsulatum infection. No cross-reactive immunostaining was 
observed with Candida species, A. elegans (Figure IB, (-/-)), R. oryzae (Figure ID, (-/-)) 
and H. capsulatum. Immunostaining was observed in P. boydii mycelial elements, 
although the majority of elements showed no reactivity. Background staining was 
observed to be mild in infections in which there was frank necrosis, and did not hamper 
the detection of the microorganisms. In vital lung tissue cross-reactivity of the antibody 
was observed in epithlial cells lining the alveoli and in alveolar macrophages. Immuno­
staining in these specimens was sometimes quite intense, however, mycelial elements 
were easily identified on the basis of their very different morphology. 
Fungal elements were detected in PAS and GMS staining in all but 2 positively 
immunostaining cases. In general, detection of microorganisms with the conventional 
methods was more difficult than after immunostaining. 
Discussion 
An accurate identification of fungal elements in tissue sections utilizing conventional 
fungal stains requires considerable knowlegde of fungal morphology, and remains difficult 
when based on morphologic features alone. This is particulary difficult for histo-
pathologists who are usually not well versed in fungus morphology. Especially the 
histological differentiation of Aspergillus species from Fusarium species and P. boydii is 
difficult since these fungi may induce similar clinical features and exhibit filamentous 
development in host tissue. 
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Figure 1. Immunostaining of formalin-fixed, paraffin-embedded tissue sections with the 
monoclonal antibody EB-ΑΙ. A, Aspergillus fumigatus in lung tissue (+ + + +/+ + +), note 
intense immunostaining of conidiophore (arrow); B, Apophysomyces elegans in necrotic bone 
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гідоде (-/-Л microorganism stains due to counterstain with H&E; C, Aspergillus flavus in lung 
tissue (+ + + +/+ + +); D, Rhizopus oryzae in lung tissue. No immunostaining (-/-), counterstain 
with H&E highlights fungal elements. 
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Although subtle morphologic features, such as dichotomous branching at 45° of 
Aspergillus mycelium, may help to differentiate this fungus from other filamentous fungi, 
only a presumptive diagnosis can be made when cultures remain negative. 
Immunohistochemistry using mono- or polyclonal antibodies capable of detecting specific 
fungi in tissue sections has been shown to be helpful in this respect9',0'5β·80·β,·91. A 
drawback however is that only genera of fungi can be differentiated. An advantage of 
immunostaining is that formalin-fixed, paraffin-embedded sections are used and that the 
staining method is relatively easy to perform. In the present study, immunoperoxidase 
staining with EB-ΑΙ proved useful for the generic identification of Aspergillus species in 
tissue sections. The presence of Aspergillus organisms was confirmed in 17 of 19 culture 
positive tissue sections and in one case fungal mycelium was identified as Aspergillus 
species in a culture negative tissue section. Cross-reactivity with three Candida species, 
two Zygomycete species, and H. capsulatum was not observed. 
An important factor in the evaluation of any immunohistochemical method is the 
estimation of background staining in relation to positively staining microorganisms. We 
did note low levels of background staining in proteinecious edema fluid in the lungs and 
also sometimes in exsudâtes as well as alveolar macrophages. The levels of background 
staining were low and usually did not deter identification of the fungi. In some cases, 
however, macrophages did demonstrate higher levels of immunostaining, reflecting the 
high concentrations of endogenous peroxidases within these cells, again this staining did 
not make fungal identification more difficult. 
Immunofluorescence studies have shown that Aspergillus, Fusarium, and P. boydii are 
antigenically closely related54. Previous observations indicated that the monoclonal 
antibody EB-ΑΙ does not cross-react with Fusarium species', but the reactivity with P. 
boydii was not ascertained. Our results suggest that EB-ΑΙ can also differentiate 
Aspergillus organisms from P. boydii. Although some cross-reactive staining occured with 
the P. boydii hyphae, the intensity of immunostaining was low and the majority of 
elements were not immunodecorated. 
The monoclonal antibody EB-ΑΙ has been shown to cross-react with Pénicillium 
mameffe?10 which has some immunodominant epitopes in the cell wall which are 
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identical to those of Aspergillus species". Invasive infections with both Aspergillus 
species30 and P. marneffef0 have been reported in AIDS patients and therefore the 
monclonal antibody EB-ΑΙ cannot be used to differentiate these fungi. Since, the tissue 
form of P. mameffei develops as a yeast-like structure", differentiation from Aspergillus 
species can be made by histologic examination with conventional fungal stains. However, 
histologic examination should be interpreted with caution because elongated forms or 
filamentous development of P. mameffei have been reported to occur in the stratum 
comeum of the skin10, in liver and lung tissue specimens of an AIDS patient48, and in 
pulmonary cavities28. 
In conclusion, immunoperoxidase staining with EB-ΑΙ in formalin-fixed and paraffin-
embedded tissue allows a generic diagnosis of invasive infections due to Aspergillus 
species in the case of negative cultures. In routine laboratory practice this method is 
superior to conventional PAS and GMS staining. However, the results should be 
interpreted in the whole clinical context of the patient, because false negative results and 
cross-reactivity with P. mameffei may occur. 
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Summary 
In the last several years there has been a measure of progress in diagnosing invasive 
aspergillosis at an early stage of disease. Polymerase chain reaction (PCR) assay's have 
been found to be more sensitive than culture in detecting Aspergillus species in bronchoal-
veolar lavage (BAL) fluid specimens but the diagnostic reliability may be diminished by 
false-positive reactions obtained from patients colonized with Aspergillus conidia or by 
laboratory contamination. Aspergillus antigens can be detected by latex agglutination (LA) 
test but the commercial Pastorex Aspergillus (Sanofi Diagnostics Pasteur, France) was 
found to be too insensitive to diagnose invasive aspergillosis early. This same company 
therefore developed a sandwich ELISA using the same monoclonal antibody to galacto-
mannan which was almost 10 times more sensitive than the LA test, and detected 
Aspergillus antigen in the serum at an earlier stage of infection. The development of 
sensitive diagnostic methods such as these offers an opportunity for optimising diagnosis 
and improving the management of invasive aspergillosis. Patients at high risk can be 
identified by regular, serial monitoring of serum samples during the period of greatest 
risk, and, if positive, the diagnosis can be substantiated by pulmonary CT-scan and PCR 
analysis of BAL fluid and treatment with antifungal agents can be initiated pre-emptively. 
By allowing selective targeting of patients for antifungal therapy to pre-empte invasive 
aspergillosis, the outlook for patients at risk should be improved in terms of both 
morbidity and mortality. 
Introduction 
The fungus Aspergillus is an unbiquitous saprophyte which can cause opportunistic 
infections in immunocompromised patients. Aspergillus fumigatus is the most common 
species encountered in human disease. Before infections can occur, Aspergillus conidia 
must be inhaled and lodge in the airways. Germination can occur in the paranasal sinuses 
but most often takes place in the alveoli of the lung when the number of alveolar 
macrophages is decreased or their ability to kill is severely impaired. Once mycelia 
develop and invade the adjacent tissue, pulmonary infection results which may dissemina-
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te to other organs. Those at high risk of invasive aspergillosis include patients who are 
neutropenic as a result of cytotoxic therapy, those receiving prolonged courses of high-
dose corticosteroids, recipients of organ transplants, and patients with AIDS. The 
incidence of infection and the period of greatest risk are listed in Table 1 although the 
overall incidence of invasive aspergillosis, even in those most predisposed to infection is 
variable and often unpredictable. Nonetheless, the disease is potentially fatal and is 
therefore a serious complication especially when it threatens the survival of patients with 
an otherwise good life expectancy. 
Several strategies can be adopted to reduce the morbidity and mortality associated with 
invasive aspergillosis most important of which, is to reduce exposure of immunocompro­
mised patients to conidia by air filtration110. The administration of antifungal agents for 
prophylaxis in order to prevent germinated Aspergillus conidia from invading tissue may 
also be effective although convincing data are lacking143. Attempts should be made to 
reduce other risk factors, such as restricting the use of broad-spectrum antibiotics2, or 
minimising the duration of granulocytopenia by administering hematopoietic growth 
factors15. 
Table 1. Incidence of invasive aspergillosis in susceptible patient groups and time period of 
greatest risk of infection. 
Host group Incidence of Time period Reference 
invasive asper- of highest 
gillosis risk (days) 
Allogeneic bone marrow transplantation 3.8 - 8.7% 
Autologous bone marrow transplantation 0-4.5% 
Peripheral stem-cell bone marrow transplantation 5.6% 
Kidney transplantation 0-2.8% 
Liver transplantation 1.5-14.7% 
Heart-lung transplantation 3 - 19% 
Heart transplantation 0 - 24% 
HIV/AIDS 0.3% 
Cytotoxic-therapy induced granulocytopenia up to 70% 
"P = posttransplant. 
'Advanced stages of AIDS in addition to specific risk factors. 
0-90P* 
0 - 9 0 Ρ 
0 - 9 0 Ρ 
30 - 90 Ρ 
14- 100 Ρ 
9 - 9 0 Ρ 
12 - 45 Ρ 
_ь 
> 22 
49,76 
49,76 
49 
121,138 
25,65,66 
60 
46 
30,56,72,93 
41,109 
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More potent, and less toxic antifungal agents are also being developed and investiga-
ted70.Timely diagnosis presents the main obstacle to managing invasive aspergillosis 
espacially as treating infection as early as possible is essential for treatment to prove 
effective. However, clinical signs and symptoms, and plain chest X-rays are neither 
specific nor sensitive and a definitive diagnosis can only be made by demonstrating 
histologically invasion of tissues by the fungus and recovering Aspergillus species in 
culture. Unfortunately, neutropenia induced by cytotoxic therapy is usually accompanied 
by severe thrombocytopenia which often precludes the use of invasive methods for 
diagnosis. Culture of sputum or expectorated bronchial secretions is regarded as being 
useful in diagnosing invasive aspergillosis in neutropenic patients144, even though the 
sensitivity is only 25%". Specimens for microbiological analysis may be obtained by 
fiber-optic bronchoscopy in some cases and, although the recovery of Aspergillus species 
from bronchoalveolar lavage (BAL) fluid is highly indicative of invasive aspergillosis, the 
sensitivity of the technique (ranges from 40-58%)71·104·112·146 and the diagnostic yield is 
low, especially in patients with focal pulmonary lesions76. The difficulty in establishing 
the diagnosis of invasive aspergillosis has led to the definition of categories which reflect 
the reliability of diagnosis (Figure 1). 
The diagnosis of invasive aspergillosis should ideally be made at an early stage of 
infection because successful treatment depends upon intervening before fungal proliferati-
on becomes overwhelming1. Within the past three years several methods have been 
developed to assist the early detection of Aspergillus species. Among these methods, those 
that detect the antigen galactomannan and DNA in clinical specimens from immunocom-
promised patients appear most promising. 
Detection of Aspergillus DNA by polymerase chain reaction 
A large burden of fungal mycelium is required to successfully diagnose invasive aspergil-
losis which renders culture of BAL fluid samples relatively insensitive and the fungus is 
often only detected at an advanced stage of the disease. The use of oligonucleotide 
primers to amplify specific fragments of Aspergillus DNA in BAL fluid by polymerase 
chain reaction (PCR) may allow small amounts of Aspergillus DNA to be detected so 
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Figure 1. Key diagnostic features for the diagnosis of invasive aspergillosis in relation to the 
spectrum of probability. 
permitting invasive aspergillosis to be diagnosed at an earlier stage of infection. Several 
PCR assay's have been developed including those which amplify DNA fragments from 
Aspergillus fumigatus alone97·"1 and those which react with the DNA of a wider range of 
the Aspergillus species involved in human disease'8,78,119. PCR assay of BAL fluid from 
patients suspected of having invasive aspergillosis was found to be more sensitive than 
culture of the same material18·78·97,111·119. PCR can detect Aspergillus specifically but needs 
to be combined with Southem-blot hybridization18·78'7·111·119 and restriction enzyme 
analysis78, to differentiate the fungus from other genetically closely related filamentous 
fungi such as Pénicillium mameffei and Paecilomyces variotif*·111·"1. Such PCR assays 
might prove valuable in diagnosing invasive aspergillosis early. 
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However, the reliability of the PCR may be reduced by the occurrence of false-positive or 
false-negative results or by positive results due to colonization of the respiratory tract 
without infection. For instance, positive amplification reactions were observed in 6 - 23 % 
of BAL fluid samples from immunocompromised patients who had no evidence of 
invasive aspergillosis18'78·119 and in up to 15% of similar specimens from non-neutropenic 
patients119·1". False positive reactions can result from contamination by Aspergillus 
conidia of biological samples or reaction buffers and can be overcome, partly, by 
ensuring that each step in the process is strictly segregated67 and that reaction buffers are 
stored in small volumes and used only once. Aspergillus species may colonize the 
respiratory tract of some patients, such as smokers, those with cystic fibrosis", those 
receiving corticosteroids, and patients with AIDS'3. We found a significant higher number 
of positive PCR results in BAL fluid samples from smokers and non-neutropenic patients 
receiving corticosteroids, when compared to those from patients without these risk 
factors127. Therefore, the PCR result should be interpreted cautiously and always in the 
clinical context of the patient. False-negative results also occur due to the presence of 
residual inhibitors of the amplification reaction18·127 and can be minimised by using 
competitive PCR18 or several dilution steps. 
If the PCR assay is to prove helpful in diagnosing invasive aspergillosis early, the 
optimum method and technique and schedule for obtaining samples need to be defined and 
the diagnostic value has to be established in prospective studies. 
Detection of Aspergillus antigens in body fluids 
Since the detection of specific antibodies to Aspergillus is very insensitive145, attention has 
been increasingly focussed upon the development of tests for detecting antigen. Several 
in-house serological methods have been developed which employ uncharacterized 
polysaccharides and (glyco)protein antigens oí Aspergillus species4·45·101·102·117 which can be 
detected in patient serum, urine, and in BAL fluid samples4. However, most research has 
focussed on galactomannan (GM), a major cell wall component in Aspergillus species that 
is released during growth in vivo and may also be secreted into the culture medium under 
certain circumstances45. Rat monoclonal antibodies raised against Aspergillus GM have 
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been applied to diagnose invasive aspergillosis serologically"·" and immunohistochemi-
cally". The rat monoclonal antibody EB-A2 is the basis of the commercial Pastorex 
Aspergillus latex agglutination (LA) test (Sanofi Diagnostics Pasteur, Marnes-La-Coquet-
te, France)114 which has been evaluated extensively using serum and urine7·31·44·47,57,75,123,128, 
137
 as well as BAL fluid3'72. Several reports suggested that the sensitivty of the LA test in 
serum samples from patients with a high index of suspicion for invasive aspergillosis 
approached 95 %31,44 and that antigen could be detected earlier than was possible using 
conventional tests in 68% of patients with proven invasive aspergillosis44. These ob-
servations were not confirmed by others7,47,57,75,128·137. Moreover, the latex test yielded a 
sensitivity of only 38% in one series75 and was found to yield positive results only during 
advanced stages of infection in other studies47,128. The LA test was found positive in BAL 
fluid samples from three patients with AIDS and invasive aspergillosis72. However, under 
experimental conditions, no GM was detected by the LA test in BAL fluid from 14 
untreated rabbits with invasive pulmonary aspergillosis, while serum samples were found 
positive in 10 (71%) animals39. Nevertheless, the LA test appears very specific although 
significant cross-reactivity with the antigens of certain other fungi including airborne 
contaminants may occur52. Thus, the LA test may contribute to the diagnosis of invasive 
aspergillosis when cultures remain negative provided that serial serum samples are obtai-
ned, but the test does not allow early diagnosis. Recently, a sandwich ELISA was 
developed which employs the same monoclonal antibody as the LA test"6 but was more 
sensitive because the antibody functioned both as a captor and detector thereby allowing 
the detection limit to be lowered 10-fold to 0.5 - 1.0 ng/ml. The ELISA test made it 
possible to detect GM in serum samples from more patients than was achieved with the 
LA test yielding a sensitivity of 90% when a series of serum samples was employed129. 
Furthermore, GM was detected by ELISA at an earlier stage of infection, even before 
clinical signs and symptoms had become apparent116. The increase in sensitivity of the 
ELISA also allowed detection of GM in BAL fluid samples from patients suspected of 
invasive aspergillosis, and an excellent correlation was found between these results and 
those found in corresponding serum samples130. GM was detected in serum of four 
patients from whom samples had been obtained within six weeks before bronchoscopy 
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was performed, which suggests that GM may be detected by ELISA in the serum before 
pulmonary infiltrates are visible on plain chest X-ray130. Although the increase in 
sensitivity of the ELISA test was accompanied by a false-positives rate of 8%, a specifici-
ty of 84% was obtained when a seríes of serum samples were employed129. 
Prospects for early diagnosis of invasive aspergillosis 
The diagnosis of invasive aspergillosis requires a multi-disciplinary approach. The 
development of new sensitive microbiological and imaging techniques, including ultrafast 
computerized tomography62·13*, has implications for the optimal diagnostic work-up and 
improved management of invasive aspergillosis. Since the prognosis of invasive asper-
gillosis is uniformly poor and early diagnostic procedures for establishing a reliable 
diagnosis are generally lacking, the practice of initiating early empiric antifungal therapy 
to high-risk patients has become widespread in order to treat occult fungal infections 
promptly2*. This approach appears benefitial to febrile granulocytopenic patients who 
remain febrile despite broad-spectrum antibacterial therapy1·20,21,33·'2·135'136. However, fever 
is a non-specific sign of infection and a considerable group of granulocytopenic patients 
who do not have fungal infection will receive antifungal treatment, usually with amphote-
ricin В desoxycholate which is relatively toxic. Less toxic lipid formulations of 
amphotericin В are available but are so costly that treatment has to be limited to those 
patients with proven disease or to those showing signs of toxic reactions to amphotericin 
В desoxycholate. On the other hand, persistant fever may be due to concurrent infections 
caused by other microorganisms and may obscure the presence of invasive aspergillosis, 
thus delaying diagnosis further82. Patients at high risk of deep fungal infections can be 
identified by the presence of specific risk factors predisposing to fungal infection and 
guidelines for recognizing high-risk patients most likely to benefit from the empiric use of 
amphotericin В during neutropenia or after bone marrow transplantation have been 
proposed by Fraser and Denning40. However, risk factors for fungal infections, including 
invasive aspergillosis, have yet to be established for other patient groups such as solid-
organ recipients who are also at high-risk88. 
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Figure 2. Suggested guidelines for identification of patients at high risk for invasive aspergillosis 
and use of pre-emptive antifungal therapy during neutropenia induced by cytotoxic therapy or 
following organ transplantation with a high risk for invasive aspergillosis (e.g. bone marrow, 
heart-lung and liver transplantation). 
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The development of the sandwich ELISA technique to detect GM allows an alternative 
approach to identifying patients at high risk for invasive aspergillosis even whether or not 
specific risk factors are identified. A single test is not sufficiently sensitive to identify all 
patients at risk so regular, serial monitoring of plasma or serum during the entire period 
of greatest risk is required. This is likely to prove the most productive approach to 
diagnosing invasive aspergillosis early thereby allowing more selective targeting of 
empiric antifungal treatment. The most efficient approach for each patient group will 
depend upon several factors including the underlying disease, the type and degree of 
immunosuppressive therapy, the incidence of invasive aspergillosis in that particular 
patient population, the environment, the availability and sophistication of radiological 
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facilities and, the possibility of using invasive diagnostic procedures. Guidelines which 
may be applied to patients with hematological malignancies during the period of neutrope-
nia induced by cytotoxic-therapy or to transplant recipients with a high risk for invasive 
aspergillosis (e.g. bone marrow, heart-lung and liver transplantation) are shown in Figure 
2. Plasma or serum from each patient is monitored regularly for the presence of GM 
using the ELISA technique and key clinical signs and symptoms, other laboratory results, 
and radiological features of the lung are registered systematically. When GM is detected 
for the first time, further confirmation should be sought by obtaining additional plasma or 
serum samples for ELISA. In addition, a CT-scan should be performed and, where 
possible, BAL fluid should be obtained for PCR analysis. Once the presence of GM is 
confirmed or, there are signs of infection almost pathognomonic for invasive aspergillosis 
such as the 'crescent sign' on a pulmonary CT-scan, treatment with antifungal agents 
should be started pre-emptively. In order to identify when treatment is failing to control 
the infection67, the response should be monitored by following the course of GM levels 
using the ELISA technique11* and by regular CT scans13*. 
A more individual approach needs to be adopted for patients at a lower risk of invasive 
aspergillosis and for those for whom the risk is not predictable such as recipients of 
kidney transplants, patients receiving a prolonged course of high-dose corticosteroids, and 
those with AIDS. For instance, plasma or serum might be monitored for GM levels only 
when fever persists for more than 4 days despite an adequate trial of broad-spectrum 
antibiotics or when the risk of Aspergillus infection is increased by anti-rejection therapy. 
By combining novel approaches to the early diagnosis of invasive aspergillosis with pre-
emptive therapy, the outlook for patients at risk of invasive aspergillosis should be 
improved in terms of both morbidity and mortality. Moreover, the cost/benefit ratio may 
prove more favourable when only those at greatest risk of invasive aspergillosis are 
treated as the others for whom the risk is negligible would no longer receive antifungal 
treatment empirically. The results of prospective studies now underway are therefore 
eagerly awaited since, if this approach proves successful, it may be possible to implement 
similar guidelines for the early diagnosis of other deep fungal infections in immunocom-
promised patients. 
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SUMMARY 
The microbiological diagnosis of invasive aspergillosis by conventional methods lacks 
sensitivity and positive results are often obtained only during advanced infection. In this 
thesis two methods are descibed and evaluated which may allow the diagnosis at an early 
stage of disease. Chapter 1 describes the development and evaluation of a PCR assay 
which detects Aspergillus DNA fragments. For this assay the nucleotide sequences of the 
genes encoding for the 18S rRNA of four Aspergillus species were elucidated. Since 
cross-reactivity with other fungi might impair the specificity of the assay, the nucleotide 
sequences were also elucidated for three related filamentous fungi. Phylogenetic analysis 
and comparison was performed with the sequenced fungi and the 18S rRNA sequences of 
23 other eukaryotes. By this analysis, the genera Aspergillus, Paecilomyces and Pénicilli-
um were divided into two coherent clusters and showed a close intergeneric relationship 
which is in keeping with the existing morphological and taxonomie classification (chapter 
1.1). Έοτ Aspergillus specific detection genus-specific sequences were selected in the V7 
to V9 region of the 18S rRNA. By using hot-start PCR, Southern blot hybridization, and 
restriction enzyme analysis, Aspergillus-specific and -sensitive determination was achieved 
(chapter 1.3). A positive amplification reaction was found by Aspergillus genus-specific 
PCR with 11 of 72 (15%) BAL fluid samples from non-neutropenic patients at low risk 
for invasive aspergillosis. A positive PCR result was associated with corticosteroid 
therapy and cigarette smoking (p<0.05)(chapter 1.2). In immunocompromised patients 
positive PCR results were obtained from culture-negative BAL fluid samples from two 
patients suspected of invasive aspergillosis and three neutropenic patients with fever and 
pulmonary infiltrates (chapter 1.3). These results indicate that PCR analysis of BAL fluid 
samples may allow an early diagnosis of invasive aspergillosis, but prospective evaluation 
is needed to determine the diagnostic value. 
Aspergillus antigen detection may be used to diagnose invasive aspergillosis (chapters 2 
and 3). The monoclonal antibody EB-A2 raised against Aspergillus galactomannan is the 
basis of a commercially available latex agglutination (LA) test (Pastorex Aspergillus, 
Sanofi Diagnostics Pasteur, France). Galactomannan was detected by the LA test in serum 
samples from eight patients which clinical, radiological or histopathological evidence for 
invasive aspergillosis (chapter 2.1). However, in most of these patients a positive LA test 
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was obtained only during advanced disease. Furthermore, the LA test failed to detect 
galactomannan in serum samples from two patients with a proven Aspergillus infection. A 
good reproducibility of the LA test was maintained when serum samples were stored at 
-70°C. A sandwich ELISA which employs the same monoclonal antibody as the LA test 
was evaluated in serum samples obtained from 61 immunocompromised patients (chapter 
2.2). The ELISA gave positive results earlier in the course of infection than did the LA 
test. A sensitivity of 90% and a specificity of 84% were obtained for the ELISA when a 
series of serum samples was employed. Galactomannan was also detected by ELISA in 
BAL fluid samples from patients receiving treatment for hematological malignancies with 
fever and pulmonary infiltrates (chapter 2.3). An excellent correlation was found between 
ELISA results in serum and BAL fluid. Moreover, in four patients galactomannan was 
detected in serum samples which were collected within six weeks before the BAL was 
obtained. These results indicate that Aspergillus antigen detection in serum may allow the 
diagnosis of invasive aspergillosis at an early stage of infection. 
The demonstration of tissue invasion in biopsy specimens or at autopsy and a positive 
culture for Aspergillus species allows a definitive etiological diagnosis of invasive 
aspergillosis. A diagnosis by histological examination of tissue sections alone may not be 
reliable because several filamentous fungi cannot be differentiated from Aspergillus. An 
immunoperoxidase stain which employs the monoclonal antibody EB-ΑΙ allowed detection 
and generic identification of Aspergillus species in tissue sections from patients with a 
proven invasive aspergillosis and therefore may help to establish an etiological diagnosis 
(chapter 3). Since cross-reactivity with Pénicillium marneffei has been reported, 
immunoperoxidase staining should be related to fungal morphology and interpreted in the 
clinical context of the patient. 
The diagnosis of invasive aspergillosis requires a multi-disciplinary approach. The 
development of these sensitive microbiological diagnostic methods has implications for the 
optimal diagnostic work-up and management of invasive aspergillosis (chapter 4). Regular 
monitoring of the galactomannan level in serum samples from patients during the period 
of highest risk may allow early identification and selection of patients for antifungal 
treatment. When a positve ELISA result is confirmed by ELISA with additional serum 
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samples, pulmonary CT scan and PCR analysis of BAL fluid, pre-emptive antifungal 
therapy can be initiated. By using this approach the outlook for patients at risk of invasive 
aspergillosis should be improved in terms of both morbidity and mortality, and the results 
of prospective studies now underway are therefore eagerly awaited. 
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De microbiologische diagnose van invasieve aspergillose met behulp van conventionele 
methoden is weinig sensitief en positieve resultaten worden vaak pas verkregen tijdens een 
vergevorderd stadium van infectie. In dit proefschrift worden twee methoden beschreven 
en geëvalueerd die mogelijk kunnen bijdragen aan het vroegtijdig stellen van de diagnose. 
In hoofdstuk 1 wordt de ontwikkeling en de resultaten van de evaluatie van een PCR test 
beschreven, waarmee Aspergillus DNA aangetoond kan worden. Hiertoe werd de 
nucleotide volgorde bepaald van de genen die coderen voor het 18S rRNA van vier 
Aspergillus species. Omdat kruisreactiviteit met andere filamenteuze schimmels een lage 
specificiteit tot gevolg kan hebben, werd tevens de nucleotide volgorde bepaald van drie 
nauw verwante schimmels. Phylogenetisch onderzoek werd verricht met de onderzochte 
schimmels en de 18S rRNA sequenties van 23 andere eukaryoten. Hierbij werden de 
genera Aspergillus, Pénicillium en Paecilomyces verdeeld in twee clusters die een nauwe 
intergenerische verwantschap vertoonden, wat in overeenstemming is met de huidige 
morfologische en taxonomische classificatie (hoofdstuk 1.1). Aspergillus specifieke 
detectie werd bereikt door genus specifieke nucleotide sequenties in het V7 - V9 regio te 
selecteren. Met behulp van hot-start PCR, Southem blot hybridizatie, en digestie met 
restrictie enzymen was het mogelijk met een hoge specificiteit en sensitiviteit Aspergillus 
aan te tonen (hoofdstuk 1.3). In bronchoalveolair lavage (BAL) vloeistof monsters van 70 
niet-neutropene patiënten, die een laag risico hadden om een invasieve Aspergillus infectie 
door te maken, werd in monsters van 11 (15%) patiënten een positieve amplificatie 
gevonden. Een positieve PCR uitslag was geassocieerd met corticosteroid therapie en het 
roken van sigaretten (p<0.05)(hoofdstuk 1.2). Bij immuungecompromitteerde patiënten 
werd Aspergillus DNA aangetoond in BAL vloeistof van twee patiënten die verdacht 
werden voor invasieve aspergillose en van drie patiënten met koorts en longinfiltraten 
(hoofdstuk 1.3). Deze resultaten wijzen erop dat de PCR bruikbaar is voor de vroege 
diagnose van invasieve aspergillose, maar de diagnostische waarde dient geëvalueerd te 
worden in prospectief onderzoek. 
Het aantonen van Aspergillus antigenen kan gebruikt worden voor de diagnostiek van 
invasieve aspergillose (hoofdstuk 2 en 3). Het monoclonale antilichaam EB-A2, gericht 
tegen het galactomannan, vormt de basis van een commercieel verkrijgbare latexagglutina-
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tie test (Pastorex Aspergillus, Sanofi Diagnostics Pasteur, Frankrijk). Met behulp van 
deze test kon galactomannan aangetoond worden in serum monsters van acht patiënten 
met klinische, radiologische of microbiologische aanwijzingen voor invasieve aspergillose 
(hoofdstuk 2.1). Echter, in de meeste patiënten werd de test voor het eerst positief in een 
vergevorderd stadium van de infectie. Bij twee patiënten met een bewezen Aspergillus 
infectie werd geen galactomannan aangetoond in het serum. Een goede reproduceerbaar-
heid van de test werd bereikt door de serum monsters te bewaren bij -70°C. Een 
sandwich ELISA die gebruik maakt van hetzelfde monoclonale antilichaam als de latex 
test werd geëvalueerd in serum monsters van 61 immuungecompromitteerde patiënten 
(hoofdstuk 2.2). In vergelijking met de latex test kon met behulp van de ELISA galacto-
mannan aangetoond worden in serum monsters die in een vroegtijdig stadium van infectie 
waren afgenomen. Een sensitiviteit en specificiteit van respectievelijk 90% en 84% werd 
bereikt wanneer meerdere achtereenvolgende serum monsters werden getest. Galacto-
mannan kon met de ELISA ook aangetoond worden in BAL vloeistof van patiënten, die 
behandeld werden voor hematologische maligniteiten, met koorts en longinfiltraten 
(hoofdstuk 2.3). Een zeer goede correlatie werd gevonden tussen de ELISA resultaten in 
BAL vloeistof en de bepalingen in het serum. Bij vier patiënten werd galactomannan 
aangetoond in serum monsters die afgenomen waren binnen zes weken voorafgaande aan 
de BAL. Deze resultaten wijzen erop dat deze ELISA gebruikt kan worden om vroegtijdig 
invasieve aspergillose te diagnostiseren. 
Een definitieve etiologische diagnose van invasieve aspergillose kan alleen gesteld worden 
door het aantonen van schimmeldraden in weefselcoupes én een positieve Aspergillus 
kweek. Het stellen van de diagnose op basis van histologie alleen kan onbetrouwbaar zijn 
omdat met routine kleuringen het microscopisch beeld van Aspergillus niet onderscheiden 
kan worden met dat van andere filamenteuze schimmels. Met behulp van een immuno-
peroxidase kleuring, die gebruik maakt van het anti-galactomannan antilichaam EB-A1, 
was het mogelijk Aspergillus schimmeldraden aan te tonen in weefselcoupes van patiënten 
met een bewezen invasieve aspergillose en daarmee een generische identificatie te 
verkrijgen (hoofdstuk 3). Omdat het monoclonale antilichaam kruisreacties vertoonde met 
Pénicillium mameffei dient de immunoperoxidase kleuring gerelateerd te worden aan de 
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morfologie en de klinische gegevens. 
Het stellen van de diagnose invasieve aspergillose vereist een mulo-disciplinaire benade-
ring. Het beschikbaar komen van deze gevoelige microbiologische diagnostische methoden 
heeft implicaties voor de diagnostische benadering en behandeling van patiënten met 
invasieve aspergillose (hoofdstuk 4). Het regelmatig monitoren van galactomannan 
spiegels in serum monsters van patiënten tijdens de periode waarin het risico het hoogst is 
zou een vroegtijdige diagnose en selectie van patiënten voor behandeling tot gevolg 
kunnen hebben. Wanneer een positieve ELISA titer gevonden wordt dient deze bevestigd 
te worden met ELISA bepalingen met nieuwe serum monsters, CT scan van de thorax, en 
PCR onderzoek van de BAL vloeistof. Na confirmatie kan pre-emptieve therapie met 
antifungaie middelen gestart worden. Met deze benadering zou mogelijk de morbiditeit en 
letaliteit van invasieve aspergillose verbeterd kunnen worden, maar dienen eerst de 
resultaten van prospectief verricht onderzoek afgewacht te worden. 
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Stellingen 
bij het proefschrift 
MICROBIOLOGICAL DIAGNOSIS OF INVASIVE ASPERGILLOSIS 
I 
De voorwaarde voor vroegtijdige diagnose van invasieve aspergillose, met behulp van de 
sandwich ELISA, is regelmatige bemonstering. 
II 
De op handen zijnde kostenexplosie na de registratie en ten gevolge van onterecht gebruik 
van liposomale antifungaie middelen, vereist een protocollaire multidisciplinaire diagnos-
tiek van invasieve aspergillose. 
III 
Preventie van invasieve aspergillose met behulp van HEPA-filters op patiëntenkamers is 
zinloos, indien deze filters niet ook geplaatst worden in onderzoekkamers, gangen en 
toiletten. 
IV 
De relatie tussen bouwactiviteiten in ziekenhuizen en het optreden van invasieve infecties 
met Aspergillus species veronderstelt dat het opschrift "Wij bouwen aan de toekomst" niet 
van toepassing is op patiënten, die behandeld worden voor een hematologische maligni-
teit. 
V 
"Beter één Aspergillus spore in de hand dan tien in de lucht" is wel van toepassing op de 
neutropene patiënt, maar niet op de moleculaire diagnostiek van Aspergillus infecties. 
VI 
The essence of wisdom is to make empirie decisions on inadequate evidence. 
VII 
Gezien de inhoud van de biobak tijdens warme zomermaanden, kan de betekenis van de 
afkorting GFT (Groente- Fruit- en luinafval) beter vervangen worden door Gevaarlijke 
Eungi en Toxinen. 



